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CHAPTER ONE: Background 
I. Introduction 
The loss of blood flow to the brain is termed ischemia and the subsequent resumption of 
blood flow is termed reperfusion.  Brain ischemia and reperfusion (I/R) occurs primarily 
following resuscitation from cardiac arrest and/or stroke and presents one of the most significant 
clinical challenges.  At present, there are no clinically effective pharmacologic interventions to 
halt brain damage following I/R.  The major Aim of this dissertation will be to investigate 
possible mechanisms involved in neuron death following brain I/R, which may potentially lead 
to the development of effective therapies. 
A second major facet of this dissertation will be to address the issue of stroke and 
diabetes.  It is very well established clinically that stroke outcome in diabetic patients is 
significantly worse than in non-diabetic patients. Diabetes has negative effects throughout the 
whole body and multiple different causes have been attributed to worsened stroke outcome. As 
both diabetes and ischemia are stress to cells, I hypothesize that the worsened damage following 
ischemic stroke in diabetes is due to a cumulative or additive effect of each condition on 
neuronal stress responses. 
Neuronal death following brain I/R injury is a result of a variety of damage pathways5.  
The focus of the work here is on a specific aspect of I/R injury: the persistent inhibition of 
protein synthesis, or translation arrest (TA), which occurs in neurons in response to I/R injury.  
TA is of significance because, as I discuss in detail below, it correlates with neuronal death1,2.  
The purpose of this Dissertation is to investigate mechanisms of TA in the brain following focal 
ischemia, with and without diabetes.  There has been extensive research on persistent TA in 
global models of brain I/R, whereas research in focal ischemia, as occurs in stroke, has not been 
as extensive.  Therefore, there is a need to further study mechanisms of TA in the focal model.  
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After a thorough literature review, I have found no studies of the possible role of TA in worsened 
stroke outcome in diabetics, making this line of investigation completely novel. 
Below, I will review our current understanding of I/R brain injury and how diabetes 
worsens outcome.  I will discuss clinical outcomes, the major mechanisms, and especially focus 
on TA following brain I/R.  The most current ideas on TA link it to intracellular stress responses 
and the formation of subcellular particles involved in mRNA metabolism such as stress granules 
and mRNA granules.  My Background discussion will introduce my hypotheses about 
mechanisms of prolonged TA following focal brain I/R and the possible effect of diabetes on 
these mechanisms.  In subsequent chapters I will present my study designs and results.  The 
Dissertation will close with a chapter discussing the significance of my finding in light of the 
existent literature and in terms of new ideas about cell injury dynamics that are being developed 
in our laboratory. 
II. Brain Ischemia and Reperfusion Defined 
Ischemia is a significant decrease or cessation of blood flow to the brain, and reperfusion 
is resumption of normal or near normal blood flow.  The brain is the most sensitive organ to I/R 
injury.  I/R brain injury takes two major forms: global and focal.  Global ischemia is a cessation 
of blood flow to the entire brain and occurs in humans during drowning or during cardiac arrest.  
Focal ischemia is ischemia of a localized region of the brain and is due to many possible causes 
such as artery occlusion, ruptured hematomas, gliomas, etc. Stroke is the focal ischemia that 
most often occurs in humans.  Both focal and global ischemias are lethal to neurons and there is 
great clinical interest in determining the mechanisms of injury so as to be able to treat these 
conditions. 
III. Focal Ischemia and Reperfusion Brain Injury 
Stroke is the most common form of focal ischemic insult to the brain and is the third most 
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common cause of death and disability in the United States.3  Ischemic stroke accounts for 
approximately 80% of all strokes and results from an embolic or thrombotic occlusion of a major 
cerebral artery or its branches.  This is most often the middle cerebral artery (MCA).  Occlusion 
of a specific blood vessel results in injury to the corresponding volume of brain tissue fed by the 
occluded vessel.  Loss of the brain functions associated with the ischemic brain volume occurs 
rapidly.  Damage to the brain results from either a transient ischemic attack, where neuronal 
function will be restored ~24 hrs after the development of symptoms4, or from a stroke, where 
neuronal function is lost forever due to irreversible death of the brain tissue. 
Unlike global ischemia, which leads to neuronal cell death in very specific neuron 
populations, there is a morphological complexity to stroke injury.5  Focal ischemia produces a 
mass of damaged brain tissue termed the infarct.  Damage is expressed as the volume of the 
infarct.  A necrotic core forms at the site of the occlusion, consisting of dead brain tissue 
including neurons, glia and vascular tissue.  Surrounding the core is a penumbra characterized by 
hypoperfusion and other metabolic and functional disturbances.  If the vessel remains occluded, 
an increasing number of cells, further away from the core, will eventually be affected. These 
cells define the penumbral region, and their death occurs many hours, days or in some cases, 
months, after the initial ischemia.  Penumbral neurons that die after the ischemia are 
distinguished from the immediate necrosis of the core by the term “delayed neuronal death” 
(DND).6   
In permanent ischemia, the initial infarct is seen after 3-12 hrs.7  The infarct begins in the 
core but reaches close to its maximal size, which includes core and penumbra, 8-24 hrs after the 
onset of ischemia.  The infarct continues to grow after 1 day, so that between 24 and 72 hrs it can 
grow by approximately 30%.8  Thus damage continues to increase in penumbral regions.  
Different durations of temporary ischemia lead to graded involvement of different regions in the 
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infarct as measured after 1-2 days reperfusion.9  Studies have demonstrated that 1 hr of ischemia 
leads to infarct in the core, with infarct in the penumbra developing fully within 2-3 hr of 
temporary occlusion.10  As little as 30 minutes of transient ischemia leads to an infarct in the core 
region, but this only first appears after 3 days and takes 2-3 weeks to mature to its full size.11   
Individual cell death within the infarct develops slowly, but more rapidly than delayed 
cell death in global ischemia.  Cell death first becomes significant at approximately 6-12 hrs in 
the core of the lesion, with a major increase between these two time points.  At 12 and 24 hrs, 
approximately 80% of the neurons died.12  The final stage of infarct development in focal 
ischemia is pan-necrosis, in which neuronal death is accompanied by glial and vascular cell 
death and loss of cellular elements.5  
To conclude, development of the necrotic infarct occurs within a few hours of focal 
ischemia, but matures over up to several days, drawing in penumbral regions and resulting in a 
larger mass of dead brain tissue.  
IV. Diabetes and Worsened Stroke Outcome 
A. Diabetes Defined 
Diabetes mellitus is a metabolic disorder characterized with chronic degenerative changes 
in various tissues, with the two major forms being type 1, insulin-dependent, and type 2, 
noninsulin-dependent diabetes.  In the United States, 25.8 million people, or 8.3 % of the 
population, have diabetes, with 1.9 million new cases of diabetes diagnosed in people aged 20 
years or older in 2010.13  Type 2 diabetes accounts for ~90% of the population diagnosed with 
diabetes in the United States.  Diabetes is not just an epidemic of the US but is considered a 
global health problem, affecting over 340 million people worldwide.14  
Type 1 diabetes is an autoimmune disorder characterized by the destruction of pancreatic 
islet cells, including the insulin-producing beta cells.  However, many factors contribute to the 
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onset of type-2 diabetes, including genetic, lifestyle and dietary.  Type 2 diabetes is characterized 
by insulin resistance, relative insulin deficiency at later stages, and excessive hepatic glucose 
production, all leading to hyperglycemia.  The primary events are believed to be an initial deficit 
in insulin secretion and, in many patients, relative insulin deficiency in association with 
peripheral insulin resistance15.  Dysfunction of pancreatic beta cells, which produce insulin, is 
necessary for the development of the disease, but the nature of the primary beta cell defect is still 
unknown.  
Initiation of the insulin response depends upon the transmembranous transport of glucose 
and coupling of glucose to the glucose sensor on the beta cell.  The glucose/glucose sensor 
complex then induces an increase in glucokinase by stabilizing the protein and impairing its 
degradation.  The induction of glucokinase serves as the first step in linking intermediary 
metabolism with the insulin secretory apparatus.  Glucose transport in beta cells of type 2 
diabetes patients appears to be greatly reduced, thus shifting the control point for insulin 
secretion from glucokinase to the glucose transport system16.  Other defects in beta cell function 
in type 2 diabetes include defective glucose potentiation in response to substances that cause 
non-glucose-dependent insulin secretion, asynchronous insulin release, and a decreased 
conversion of proinsulin to insulin.   
A hallmark of type 2 diabetes is increased secretion of insulin, hyperinsulinemia, early 
on.  In later stages, because of the chronic insulin resistance in muscle and adipose cells and 
impaired beta cell function, there is a loss of the early insulin release in response to 
hyperglycemic stimuli17.  Thus, when insulin binds to its receptors, it is not able to bring about a 
response of increased glucose utilization in these cells.  With the impaired insulin production and 
secretion, glucose synthesis and output from the liver increases.  Thus, the liver in type 2 
diabetes is programmed to both overproduce and under use glucose. 
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Furthermore, in addition to the ineffectiveness of insulin in inhibiting glucose production 
in the liver, free fatty acids are deposited into tissues and inefficiently stored in adipose tissue, 
resulting in elevated circulating levels.  The elevated FFA levels also lend to the increased 
glucose production by the liver18. The ensuing glucose toxicity leads to a multitude of 
disturbances in various tissues, disrupting homeostasis throughout the body.  Chronic 
hyperglycemia and hyperlipidemia can exert deleterious effects on beta cell function.  Over time, 
both of these phenomena contribute to the progressive deterioration of glucose homeostasis 
characteristic of this disease and various long-term complications.  The long-term complications 
markedly increase the susceptibility to cardiovascular disease, including ischemic stroke. 
B. Impact of Diabetes on Stroke Occurrence and Recovery 
People with diabetes are two to four times more likely to have an atherotherombotic 
stroke than people who do not have the disease13.  Diabetes particularly affects the risk of stroke 
among younger individuals, with a more than 10-fold increase risk of stroke in the stroke 
population younger than 55 years13.  It has been demonstrated that diabetes is associated with 
vascular alterations, including cerebrovascular atherosclerosis and other abnormalities19.  There 
is compromised collateral flow throughout arterial networks, leading to a decrease in blood flow 
to the brain that further complicates stroke.  In addition, people with diabetes often have high 
blood pressure, which can also cause abnormalities in the small blood vessels of the brain and 
contribute to the increased susceptibility to stroke.  Because diabetes has the tendency to exert 
such deleterious effects on the vascular system, these factors render diabetics, at least in part, to 
be more susceptible to ischemic brain damage and worsened outcome following stroke. 
In order to investigate the impact of diabetes on stroke, neuronal cell death was assessed 
following permanent focal ischemia using the middle cerebral artery occlusion (MCAO) 
technique.  The infarct core includes the striatum and overlying cortex, areas directly fed by the 
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MCA.  Areas peripheral to the core encompass the piriformis and parietal cortex.20  However, the 
hippocampus did not display an infarct and is therefore not considered to be in the core.  As 
explained above, the current understanding is that neuronal cell death is due to necrosis 
occurring in the core and to DND in the penumbra.21  The core of the focal lesion undergoes 
massive ion and metabolite changes that, by some indicators such as ATP levels and ion 
gradients, appears to recover after transient ischemia.  However, during the reperfusion period, it 
is near impossible to prevent formation of an infarct in the core by any interventions, despite the 
initial appearance of recovery.22 
 In contrast, in the MCAO model, the penumbra can be rescued by many 
interventions5,122, indicating different mechanisms of damage in the two regions.  This is why 
defining the penumbra and the mechanisms by which neurons die in that region is of particular 
interest.  Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) was 
used to assess nucleosomal DNA fragmentation in situ in normal and diabetic animals with or 
without MCAO22.   No TUNEL positive cells were found in the cortex of normal animals, 
whereas the diabetic animals did show positive TUNEL staining in the cortical cells.  After 
permanent MCAO, TUNEL positive cells were present in the piriform and parietal cortices in the 
normal animals and were further increased in the diabetic group.  Furthermore, caspase-3 was 
also found to be increased following MCAO in normal animals and was increased above that in 
the diabetic group.22 Caspase 3 activation is most often associated with apoptosis, but in neurons, 
its activation has also been associated with neuronal remodeling that is not associated with cell 
death.23 
These studies demonstrated that focal ischemia produces cell death in the core of the 
infarct and ensuing cell death in the penumbral region, with the amount of cell death being 
augmented by the presence of diabetes.  To consider mechanisms by which diabetes worsens 
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stroke outcome, we first turn to a discussion of the established mechanisms of brain I/R injury.  
V. Established Mechanisms of Brain I/R 
Following focal ischemia, the core is not salvageable.  However, the DND associated 
with the penumbra provides a time window for therapeutic interventions.  Therefore, it is the 
goal of stroke research to understand DND in the penumbra to be able to limit stroke damage to 
only the core infarct. The DND of penumbra is very similar in both time course and mechanisms 
to the DND found in selectively vulnerable neurons after global ischemia, and therefore, findings 
in the global ischemia models are brought to bare on the focal case.  
It needs to be emphasized that, in spite of a very large amount of information (a PubMed 
search of the term “brain ischemia” gives 78,805 papers!), the cell death pathways causing DND 
following I/R injury are not known with certainty. The “acid test” of current knowledge is the 
fact that all pharmacologic clinical trials following either stroke122 or cardiac arrest and 
resuscitation24 have fully failed. Therefore, it is safe to conclude our current knowledge, in spite 
of its volume, is incomplete.  It is anticipated that a full and correct understanding of DND will 
lead to the development of clinically effective therapies.  In the following paragraphs, we review 
(1) the established damage mechanisms associated with I/R injury and (2) the stress response 
expressed by neurons following I/R injury.  
A. Ischemia  
Ischemia, independent of reperfusion, brings about various forms of cell damage, all 
surrounding the rapid loss of ATP, which is secondary to the loss of glucose and oxygen influx 
following cessation of cerebral blood flow.  In the brain, ATP loss most directly affects the 
Na+/K+-ATPase electrogenic pump, accounting for approximately 50% of ATP utilization in the 
neuron.25  Consequently, ATP loss in the brain leads to a series of events known as 
excitotoxicity.   
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1. Excitotoxicity 
Under normal conditions in a neuron, the binding of glutamate to NMDA and AMPA 
receptors causes depolarization of postsynaptic neurons via rapid influx of Na+ and Ca2+.  
Depolarization also induces Ca2+ influx through the voltage gated L- and T- calcium channels. 
This calcium influx is reversed when extra- and intracellular ion concentrations are reset, 
ultimately via the Na+ gradient created by several ATP-dependent Ca2+ pumps.  Also, continued 
glutamate excitability is halted as a result of glutamate reuptake by astroglia, in an ATP 
dependent manner.  
Following ischemia, ATP levels drop in cells because of a lack of delivery of oxygen and 
glucose and a high rate of ATP expenditure in these cells.  ATP levels are 50% of baseline in the 
first min of ischemia, and essentially zero at 4 min ischemia26. Loss of ATP halts the function of 
the Na+-K+-ATPase allowing uncontrolled ion influx, mainly through “leak channels” initially, 
and allowing ions to approach their Nernst equilibria.  The net result of the attempt of ions to 
equilibrate is a net depolarized state in the neuron.  The depolarization results in the release of 
excessive amounts of excitotoxic amino acids, namely glutamate, from presynaptic neurons into 
the extracellular space.27  Glutamate then acts by activation of NMDA and AMPA receptors.  
This leads to an uncontrolled positive feedback loop: net depolarization results in 
neurotransmitter release, the majority of which are excitatory, inducing ligand-gated 
depolarization, which causes further excitatory transmitter release, inducing further 
depolarization.  This feedback continues until releasable transmitter is depleted.  This sequence 
of events is called excitotoxicity. 
Long durations of ischemia will cause such extreme ion equilibration that cells will die 
by bursting due to a net ion influx carrying water by osmotic forces.  However, with moderate 
and clinically relevant ischemia durations, ion influx is not sufficient to burst cells, but leads to a 
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pathologically high cytoplasmic Ca2+ concentration.  Silver and Erecinska  in 1990 demonstrated 
that, during ischemia, intracellular Ca2+ concentration in neurons goes from about 10 nM to 
about 800 nM after 7 min of complete ischemia28.   
During focal ischemia, the impact of intra-ischemic depolarization is not completely 
known.  Previous studies have found that there is a wave-like spread of increased extracellular 
K+ and glutamate from the core of the lesion in a phenomenon known as “spreading 
depression”29.  The frequencies of the depolarizations are halved by either AMPA or NMDA 
antagonists, indicating that glutamate-mediated depolarization contribute at least 50%.30.  The 
evidence linking the development of damage in the penumbra to these depolarizations is 
extensive, but mainly correlative31.  The most convincing direct evidence that these 
depolarizations are damaging came about by using either KCl or electrical stimulation, which 
increased the number of depolarizations by twofold.  This resulted in an increase in the size of 
the infarct and peri-infarct damage by 30-100%31-32.  Based on these findings, the damage caused 
by the induced depolarizations suggests that the endogenous depolarizations are also damaging 
during ischemic conditions.  However, pharmacological targeting, in an effort to more directly 
establish the importance of the depolarizations, has proven to be difficult31. 
The contribution of excitotoxicity to DND has not been resolved.  One study has shown 
significant ultrastructural alterations in post-synaptic densities following I/R that persisted to at 
least 24 hr reperfusion in CA1 compared to dentate gyrus (DG)33.  However, this study failed to 
evaluate these parameters in CA3, which is also well known to have very high excitatory 
transmission, which underlies the development of temporal lobe epilepsy34. Perhaps most 
important, the extracellular levels of excitatory transmitters found in ischemic brain is much less 
than those generated by exogenous application of the transmitters required to generate cell death 
solely by an excitotoxic mechanism35.  Thus, any notion that excitotoxicity is the sole factor in 
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DND has been proven false.  Other lines of evidence suggest that the main contribution of an 
excitotoxic mechanism to DND is to allow a massive dys-regulation of cytoplasmic Ca2+.   
B. Reperfusion Damage Mechanisms 
Reperfusion results in additional damage mechanisms that compound the damage evoked 
during ischemia.  These include: free radical production, lipid peroxidation, nitrosylation, further 
alterations in cellular signaling pathways, and persistent TA.  
1. Free Radicals 
There is substantial evidence that free radical damage (today commonly known as 
reactive oxygen species or ROS) contributes to DND following brain I/R.  One consequence of 
the abnormal calcium influx in neurons during ischemia is a rapid increase in intracellular 
arachidonic acid concentration by Ca2+-activated phospholipases36-37.  Once reperfusion begins, 
the accumulated arachidonic acid can be converted to hydroperoxides by lipoxygenase.  The 
hydroperoxides can participate in lipid peroxidation by Fenton-like reactions38. Thus, oxidative 
damage occurs in reperfused neurons on the membrane as a result of lipid peroxidation39. 
Oxygen supply to ischemic cells is restored with reperfusion.  Oxygen is an essential 
substrate of the enzyme cyclooxygenase which catalyzes the addition of two oxygen molecules 
to arachidonic acid producing prostaglandin G. Prostaglandin G is subsequently peroxidized, 
forming an oxygen radical, superoxide (O2-) and prostaglandin H26. While the prostaglandins are 
known inflammatory mediators, they can also increase in lipid peroxidation in cell membranes 
that will result in changes in lipid permeability and fluidity.  This, in turn, will disrupt the 
functions of receptors, ion channels, and other proteins located on the cell membrane. 
Perturbations within the cell membrane occur as a result of the glutathione depletion during 
ischemia40, resulting in the cell’s inability to recover from damage caused by lipid peroxidation.   
In addition to reactive oxygen species, the oxygen radicals can react with nitric oxide 
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(NO) through a reaction catalyzed by NOS, forming peroxynitrite19, a reactive nitrogen species 
(RNS).  Peroxynitrite, in turn, oxidizes Fe2+ ions resulting in greater lipid peroxidation41.  In 
addition, under ischemic conditions there is a resultant burst of free oxygen radicals and the 
release of pro-apoptotic molecules due to the formation of mitochondrial permeability transition 
pores42. Following ischemia, free radicals are generated during the inflammatory response43. 
In focal ischemia, there is very little free radical change in the core as compared to the 
penumbra; this is in contrast to the ion and metabolite changes that occur.44  Free radical 
production, as measured by hydroxylation of salicylic acid, remained elevated 3 hours after the 
onset of ischemia in the penumbra, and further elevated with the onset of reperfusion.  In 
contrast, there was no increase in the core during 3 hours of ischemia, but there was an increase 
at about 4 hours reperfusion45.  Therefore, core exposure to free radicals during the main periods 
of injury development during ischemia is considered minimal with free radical production 
largely restricted to the penumbra5. 
In addition, studies have definitively shown that free radical and NO production are 
elevated for at least 6-12 h following focal ischemia46.  It has been demonstrated that elevated 
levels of superoxide, in concert with NO production, result in increased peroxynitrite production.  
It has been well established that free radicals are generated during and after both focal and global 
ischemia and conditions that reduce their accumulation should ameliorate damage, if the free 
radicals are in fact damaging.  However, cell death, induced by arachidonate activation, in NB-
104 cells is not inhibited after cells were treated with radical scavengers47. But in the same study, 
cell death induced by lipid hydroperoxides was prevented when treated with radical 
scavengers47.  Despite the apparent connection between oxygen radical formation and lipid 
peroxidation in causing cell death, studies have proven otherwise.  Although the contribution of 
free radical damage to reperfusion injury is significant, it is only part of the picture.  
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C. Inflammation  
Inflammation has been implicated as a secondary injury mechanism following stroke.  A 
growing number of recent investigations have established a critical role for leukocytes in 
bringing about tissue damage after ischemia and reperfusion in stroke.  The vascular endothelium 
promotes inflammation through the upregulation of adhesion molecules like intercellular 
adhesion molecule (ICAM)-1, E-selectin, and P-selectin, that bind to circulating leukocytes and 
facilitate their migration into the CNS48.  Once in the CNS, the production of cytotoxic 
molecules may facilitate cell death.  The macrophage and microglial response to injury may 
either be beneficial by scavenging necrotic debris or detrimental by facilitating cell death in 
neurons that would otherwise recover.   
Using MCAO, several studies have demonstrated that inflammatory events occurring at 
the blood-endothelium interface of cerebral capillaries underlie the resultant ischemic tissue 
damage.  Inflammatory cell adhesion molecules, chemokines, and cytokines have all been 
implicated in the pathogenesis of damage.  Following transient and permanent MCAO, pro-
inflammatory cytokines such as interleukin (IL)-1 and IL-6 act upon the vascular endothelium 
to increase the expression of ICAM-1, P-selectin, and E-selectin, which promote leukocyte 
adherence and accumulation.5  It has been shown that application or overexpression of the IL-1 
receptor antagonist, IL-1r, reduces infarct size49 and blockage of IL-1 converting enzyme 
reduces brain injury through decreased formation of IL-150 
In addition, cell surface receptors called integrins are activated and mediate intracellular 
inflammatory signals.  These inflammatory signals promote leukocyte migration across the 
endothelium and mediate inflammatory cascades resulting in further cerebral damage.  There is 
also an accumulation of neutrophils, which are phagocytotic white blood cells, in infarcted tissue 
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24 h after permanent or temporary focal ischemia51.   Neutrophils have been observed within the 
vessels and the parenchyma of ischemic brain after reperfusion52.  Depletion of neutrophils from 
the circulation using anti-neutrophil antibodies reduces the brain injury associated with ischemia 
and reperfusion53, suggesting a causative, but minor, role for neutrophils in brain injury.  Further 
investigation of the underlying mechanisms of inflammation may play an important role in the 
development of therapeutic treatment of stroke.  
D. Post-Ischemic Translation Arrest 
In 1971, Kleihaus and Hossmann discovered that during reperfusion, protein synthesis 
was inhibited, in spite of return of normal ATP levels54. This post-ischemic translation arrest 
(TA) has proven to be an important observation.  Subsequently research established that: (1) TA 
occurs in all post-ischemic brain regions for at least several hours1, (2) translation recovers in 
surviving brain regions, but not in regions that will die by DND, and (3) 
the TA appeared to involve a defect at the initiation stage of 
translation1.Figure 1: TA after focal ischemia and reperfusion. 
Figure 1 illustrates TA following focal ischemia induced by 
MCAO in a study conducted by Dr. Wulf Paschen2.  In this study, 
following 2 hr MCAO and durations of reperfusion indicated in the 
figure, animals were administered radioactive amino acid, and 
autoradiograms prepared.  Following ischemia, the ipsilateral 
hemisphere showed no protein synthesis in the MCA territory.  In the 
penumbral area of cerebral cortex, a slight recovery occurred at 6 hr 
reperfusion, but by 24 hr reperfusion, the recovery was not sustained and 
incorporation was lower than the 6 hr time point.  The core lesion in the 
basal ganglia never recovered translation because the cells were necrotic. But significantly, 
Figure 1 : TA after 
focal ischemia and 
reperfu-sion. Image 
from2. 
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translation never recovered in the cortical penumbra and these neurons subsequently died.   
VI. Translation Arrest and Brain I/R   
For many years, TA was considered a damage mechanism induced by I/R injury.  
However, continued work in this area has caused a shift in this viewpoint.  Instead of being seen 
as a damage mechanism, TA is now recognized as a marker of protective intracellular stress 
responses, and the persistent TA that correlates with cell death is considered a symptom of a 
dysfunctional stress response on the part of post-ischemic neurons.  What I will do in this section 
is first, discuss what has been discovered about the causes of TA during I/R, and then discuss 
how these discoveries have linked post-ischemic TA with neuronal stress responses.  I will 
discuss the role of TA in the general response of cells to exogenous stressors.  These ideas will 
provide the basis for the dissertation work I proposed. 
Most studies conducted on TA following I/R have used global ischemia models.  
Therefore most of the evidence I will discuss will be based on global models.  TA has been less 
studied in focal models, and the experiments I will propose will be aimed precisely at clarifying 
mechanisms of TA after focal ischemia, with and without diabetes. 
A. Translation Initiation 
Kleihaus and Hossmann54 in 1971 showed in their seminal study that polysomes 
dissociated immediately with the onset of reperfusion and that protein synthesis was inhibited.  
Because it was known even then that polysome dissociation was a marker of inhibition of 
translation initiation, these authors inferred that translation initiation was inhibited in the 
reperfused neurons.  Much subsequent research investigated translation initiation following I/R 
so I will now explain translation initiation. 
Protein translation consists of three steps; initiation, elongation, and termination. More 
than a dozen globular protein initiation factors are involved in the initiation step, working in 
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concert to promote the binding of mRNA, the small 40S ribosomal subunit, the large 60S 
ribosomal subunit, and the methionine-conjugated initiator tRNA.  After the formation of the 
initiation complex, initiation factors dissociate and elongation factors are recruited to allow the 
ribosome to move on the mRNA in the 5’ → 3’ direction, by which the mRNA sequence is 
translated into a primary protein sequence.  A critical aspect of the elongation phase is the 
binding of chaperone proteins to the nascent peptide, which help it to fold into its mature three-
dimensional tertiary conformation.  The termination step takes place when a special tRNA binds 
to a stop codon on the mRNA, signaling elongation termination and dissociation of the nascent 
peptide. 
There are two rate-limiting steps in translation initiation that serve as almost universal 
regulatory targets, from bacteria, through yeast, to complex metazoans including humans.  These 
steps involve eIF2, which delivers the charged initiator tRNA and eIF4, which delivers the 
mRNA to the 40S subunit. eIF4F is a heterotetramer, consisting of eIF4E, eIF4A, eIF4B, and 
eIF4G subunits55.  eIF4E binds the 5’ m7-G cap of the mRNA.  eIF4A is a helicase that, in 
association with its cofactor eIF4B, unwinds the secondary structure of the mRNA, allowing the 
ribosome to scan the mRNA.  Finally, eIF4G is a scaffold protein, providing a surface on which 
many of these binding interactions occurs56.  eIF4 is controlled by several concurrent 
mechanisms55 and the main result of eIF4 regulation is to control which mRNAs get translated. 
eIF2 determines the global rate of protein synthesis and contributes to the initiation of 
protein translation by forming a ternary complex with GTP and Met-tRNA.  Binding of the 
ternary complex to the small 40S ribosomal subunit forms the 43S preinitiation complex.  
Addition of the mRNA-eIF4 complex forms the 48S preinitiation complex.  Once initiation is 
completed, the 60S large ribosomal subunit joins, and hydrolysis of eIF2-GTP to GDP occurs, 
followed by the dissociation of eIF2 from the completed ribosomal 80S complex.  The exchange 
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of GDP bound to eIF2 for GTP is mediated by eIF2B, a guanine nucleotide exchange factor, and 
is a crucial step for the recycling of eIF2.  This is important because eIF2-GDP cannot bind the 
methionyl charged initiator tRNA to form the ternary complex and prepare eIF2 for another 
round of initiation.  Thus, the quantity of available eIF2B is the rate-limiting factor for normal 
rates of translation initiation. 
Phosphorylation of the alpha subunit of eIF2 causes a decrease in total protein synthesis 
rate.  Mechanistically, when the alpha subunit of eIF2 is phosphorylated [eIF2(αP)], it binds 
eIF2B with a much higher affinity than dephosphorylated eIF2.57  The sequestration of eIF2B by 
eIF2(αP) effectively removes it from the reaction cycle.  This in turn results in an accumulation 
of eIF2-GDP that is not able to form the ternary complex and leads to the subsequent stalling of 
ribosomes during initiation, while awaiting delivery of the initiator methionine. 
There are two established mechanisms of eIF4F regulation: (1) by phosphorylation of 
eIF4E, which increases its affinity for eIF4G, thereby increasing the formation of the eIF4 
complex58 and (2) by 4E binding proteins (4EBPs), when dephosphorylated, compete with eIF4G 
for binding to eIF4E, preventing the formation of eIF456.  eIF4G regulation is not well 
understood, but what is known is that following infection with a picornavirus, eIF4G is 
degraded59.  The main effect of decreasing available eIF4 is a quantitative shift in which types of 
mRNA are translated and a net decrease in protein translation59. 
Fragmentation of eIF4G disables 5’-capped mRNAs to be delivered to the ribosome; 
however uncapped viral mRNAs contain special nucleotide sequences in their 5’ untranslated 
regions known as an internal ribosome entry site (IRES).  The IRES allows cap-independent 
translation of viral mRNAs60.  In addition, degradation of eIF4G via caspase-3 proteolysis occurs 
during apoptosis, where important apoptotic mRNAs such as the FAS receptor and DAP5 (an 
eIF4G homolog) contain IRES sequences61. 
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B. Changes in eIF2 and eIF4 during reperfusion 
Studies of translation initiation following brain ischemia and reperfusion have revealed 
that eIF2α is phosphorylated and eIF4G is degraded62,63,64,65,66.  In 2004, Garcia et al 
demonstrated that eIF2α phosphorylation occurred with or without ischemic preconditioning 
(IPC).  IPC is an exposure to a brief, nonlethal duration of ischemia followed by a lethal dose 
two days later.67  Cell death does not occur when IPC is performed68  and therefore, eIF2α(P) 
itself is not directly involved in DND since it occurs with or without IPC.  However, degradation 
of eIF4G occurred only with long ischemia durations, while eIF2α(P) occurred even with the 
shortest ischemia durations.  
Studies of eIF2α(P) showed that it is a transient and acute response.  While eIF2α(P) 
occurs rapidly, it also dephosphorylated rapidly.  Therefore, the consensus has emerged that 
eIF2α(P) cannot be responsible for the prolonged TA associated with DND2,69,75,86. 
 Studies of eIF4 following brain I/R showed that there was no change in eIF4E, but there 
was degradation of eIF4G, which was greatest in the CA1 region of the hippocampus64,70.  The 
main finding of studies of eIF4 subunits is the calpain-mediated degradation of eIF4G following 
brain I/R.  It is not known at present in which cell types changes in eIF4G occur or the 
significance of the changes in eIF4G.  As cell death can be induced in global models without 
degradation of eIF4G72,102, its degradation cannot be considered essential to DND in global 
models. 
C. Mechanisms of Prolonged Translation Arrest 
To try to discover the cause of the persistent TA, recent work has studied mechanisms of 
TA other than the regulation of translation initiation.   There are two main models and both share 
the common idea that translational machinery is sequestered into molecular complexes that 
cannot perform protein synthesis.  These models are called cotranslational aggregation and the 
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ribonomic dysfunction models. 
1. Cotranslational Aggregations 
The first model is called cotranslational aggregation proposed by Dr. Hu’s laboratory71-72.  
Extensive studies on neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s 
disease, and prion-like diseases demonstrated an increase in unfolded proteins in pathological 
neurons73.  An improperly folded protein, like amyloid-beta peptide precursor in Alzheimer’s 
disease, is ubiquinated and accumulated as protein aggregates throughout the cytoplasm73. 
Ubiquination of improperly folded and non-functional proteins is a signal for transport to the 
proteosome and subsequent degradation.  However, since the quantity of the unfolded proteins 
exceeds the rate at which they are degraded by the proteosomes, these abnormal proteins clump 
together irreversibly throughout the cytoplasm. 
The basis for Dr. Hu’s model of cotranslational aggregation is similar to changes seen in 
chronic neurodegenerative disorders.  Studies from the Hu lab showed that two types of 
ubiquinated particles accumulate in post-ischemic neurons74,71.  The first particle was termed 
“ubi particles” because it was cytoplasmic, relatively large (diameter ~ 1 micron) and contained 
ubiquitin.  Ubi-particles are visible under the light microscope, forming in all post-ischemic 
neurons immediately with reperfusion.  However, the ubi-particles disappear from resistant areas 
by 24 hr reperfusion, but persist in the ischemic vulnerable CA1 in an altered form.  The second 
particle, termed protein aggregates (PAs), is visible only under the electron microscope and was 
roughly 200 nm in diameter.  PAs persisted in the soma and dendrites of CA1 neurons after 24 hr 
reperfusion, but were absent in resistant neurons, such as the dentate gyrus.  Later studies from 
Dr. Hu’s lab investigated the composition of PAs75. Proteins that were shown to accumulate in 
the PAs were: (1) initiation factors, such as subunits of eIF2 and eIF4, (2) protein folding 
chaperones such as HSC70, and (3) proteins that make up the 40S ands 60S ribosomal subunits 
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such as ribosomal protein S6.  Therefore, the composition of the PAs suggested they were 
involved in prolonged TA by sequestering components needed for translation.  Further, that PAs 
occurred only in ischemic vulnerable neurons such as CA1 was an unambiguous correlation with 
the time course of persistent TA and DND, something that has not been demonstrated to this 
point when only changes in initiation factors have been studied.  
Based on this evidence, Dr. Hu has proposed the following model of cotranslational 
aggregation for prolonged TA in post-ischemic CA1 neurons.  He proposes that I/R cause 
misfolding of nascent peptides during the process of translation elongation.  These then: (1) 
become targets for ubiquination, and (2) clump together.  When the misfolded nascent peptides 
clump together, they also draw the ribosomes into the aggregates of misfolded proteins, thereby 
sequestering ribosomes.  This process is what is meant by the term “cotranslational aggregation”.  
Cotranslation aggregation provides an alternative pathway, other than eIF2α phosphorylation, 
that could potentially explain why there is irreversible prolonged TA in reperfused neurons 
destined to DND. 
Although there is good evidence to support this model, it has two main weaknesses.  The 
first is quantitative.  The total amount of translational components that get sequestered in the PAs 
is ~ 10-15% of ribosomal components, and ~ 35% of co-translational chaperones.  PAs have not 
been shown to quantitatively sequester any single translational component69.  A second weakness 
of this model is that it does not take into account the regulatory changes in initiation factors that 
were described above, namely the phosphorylation of eIF2α and the degradation of eIF4G.  We 
now develop our main ideas of an alternative model for prolonged TA. 
2. Ribonomics 
This model is the working model we use in our laboratory and is the outcome of work in 
Dr. DeGracia’s lab over the past ~7 years.  Unlike Dr. Hu’s model, the ribonomic dysfunction 
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model takes into account the changes in translation initiation that have been identified by Dr. 
DeGracia, Dr. Burda, Dr. Paschen and 
other investigators over the past 
years2,63,65,.  Before explaining the 
ribonomic dysfunction model, I will first 
define the term ribonomic. 
The term “ribonomic” is similar to 
the idea of genomic or proteomic, in that 
it refers to a total complement of mRNAs 
in the cell at any given instant.  There is 
more to this idea however.  The idea is 
meant to capture the fact that there are 
many layers of regulation of the cellular 
mRNAs that begin from the point of mRNA transcription and continue to the point an mRNA is 
ultimately degraded in the cytoplasm.  In between, an mRNA molecule undergoes complex 
patterns of localization and regulation via a large number of binding partners.  Therefore, the 
idea of ribonomic refers to the regulatory interactions of mRNA molecules with either proteins 
or microRNAs76. Figure 2 The ribonomic network. 
An important aspect of the cellular ribonome is that mRNAs undergo very specific 
subcellular localization via a number of structures that have been identified to be involved in 
mRNA function (Figure 2).  The known structures in the nucleus are the splicesome and the 
mRNA nuclear transport complex.  In the cytoplasm, the structures that localize mRNAs are 
stress granules (SGs), processing bodies, HuR granules, and polysomes.  Each of these structures 
plays a role in mRNA function.  Stress granules are like a train station and route mRNAs 
Figure 2. The ribonomic network. 
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amongst the other ribonomic structures77. Processing bodies are the particles that degrade 
mRNAs, and in this regard are similar to what the proteosome is to proteins78.  Polysomes are 
now viewed as one of these mRNA control particles69, and these are where the genetic 
information coded in an mRNA gets converted to protein.  HuR granules are structures that are 
thought to bring functionally related mRNAs together to carry out complex genetic 
programs79,80.  Dr. Jack Keene, one of the leaders in studying HuR granules, invented the idea of 
“mRNA operons”81. Similar to bacterial operons, in which several genes with a coordinated 
function are translated at the same time, the mRNA operon is the HuR granule that brings 
together functionally related mRNAs so that they may be acted upon at the same time in 
eukaryotic cells.  This action may involve coordinated translation, coordinated silencing (e.g. the 
mRNAs are present but not translated), or coordinated degradation (by routing the groups of 
mRNAs to processing bodies for degradation). 
VII. The Ribonomic Model and Brain I/R 
The ideas surrounding the concept of ribonomic regulation of mRNA offers new insights 
into possible mechanisms of persistent TA following brain I/R.  Since the seminal work of 
Kleihaus and Hossmann54 the field has been focused on changes in ribosomes as the cause of 
TA.  However, mRNA is just as important to protein synthesis as ribosomes are, and there has 
been a relative neglect in the field at understanding changes in mRNA and its regulation, and its 
possible role in TA. 
There are many, many studies in the field looking at the changes in specific mRNAs 
following I/R, either by in situ hybridization or PCR.  But there are only two papers that looked 
at global changes in mRNAs following I/R.  Maruno & Yanagihara82  showed a decrease in total 
mRNA in reperfused CA1 compared to other brain regions.  A decrease in mRNA would 
contribute to TA.  Matsumoto et al83, showed, using gradient centrifugation, that there was a 
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change in the subcellular fractionation of mRNAs in vulnerable neurons following ischemia83.  
The interesting point here is that, if there are indeed major changes in mRNA following brain 
I/R, such as could be envisioned looking at the ribonomic network, then this brings into question 
the interpretations of all of the many studies that have evaluated individual mRNAs.  To date, 
there has only four studies that looked at the ribonomic network, and these have all been carried 
out in Dr. DeGracia’s lab101-102.  I will now review these studies. 
A. SGs in Reperfused Neurons 
In 2005, Kayali et al. evaluated SGs in rat hippocampal formation using the cardiac arrest 
and resuscitation model of global brain ischemia101.  SGs are known to form following 
phosphorylation of eIF2α when cells undergo stress77.  SGs have been shown to function to 
move mRNAs around the cell into other ribonomic structures where the most focus to date has 
been the movement of mRNAs from polysomes to processing bodies84.  Since eIF2α 
phosphorylation was a well established change in reperfused neurons65, Kayali et al 
hypothesized that there might be a difference in SGs between resistant (e.g. CA3) and vulnerable 
(CA1) post-ischemic neurons.  This hypothesis linked to what was already a well-established fact 
of reperfused neurons, unlike Dr. Hu’s model of cotranslational aggregation. 
A 10-minute global brain ischemia was induced by cardiac arrest followed by reperfusion 
durations of 10 min, 90 min, or 4 hours.  Double-labeling immunofluorescence (IF) for two SG 
components, S6 and TIA-1, was used for evaluation.  SGs in resistant regions, such as CA3, 
hilus, and dentate gyrus (DG) increased at 10 min reperfusion and returned to control levels by 4 
hr reperfusion (4hR), however, this was not the case in vulnerable CA1.  At 4hR, S6 was solely 
localized within SGs only in CA1 pyramidal neurons.  This study led to the conclusion that 
prolonged TA in reperfused CA1 pyramidal neurons was due to loss of the 40S ribosomal 
subunits and the complete sequestration of the remaining 40S ribosomal subunits in SGs at a 
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time when eIF2(P) has dephosphorylated  substantially85.  This conclusion related SGs and the 
persistent TA in CA1 to the acute phase of TA mediated by eIF2α phosphorylation86. It also 
provided a mechanism of the continued inhibition of protein synthesis in reperfused CA1 
pyramidal neurons after eIF2α had been dephosphorylated.   
B. Problems with the SG Mechanism  
The main limitation of the Kayali et al study was that it looked only to 4 hr reperfusion, 
which is well before the time of DND at ~ 72 hr reperfusion101.  This was a technical limitation 
due to the difficulty of keeping rats alive for longer durations following cardiac arrest and 
resuscitation.  Following cardiac arrest, rats experience severe peripheral organ damage, which 
was studied by Dr. Montie87-88.  Because of these limitations the cardiac arrest model was 
unsuitable for studying longer reperfusion durations to assess the role of SGs in neuronal death. 
The experiment was repeated with a different model of global ischemia, the bilateral 
carotid artery occlusion plus hypovolemic hypotension model (2VO/HT) of Smith et al89.  This 
model does not cause peripheral organ damage, so animals can be reperfused for any duration.  
When 10 min of ischemia was applied with the 2VO/HT model, although CA1 death occurred at 
72 hr reperfusion, there was no loss of S6 or sequestration of S6 in SGs at 4 hr reperfusion69.  
That S6 sequestration in SGs did not occur at 4 hr following 2VO/HT indicated that the SG 
mechanism of prolonged TA was not general.  In the 2VO/HT model, the number of SGs 
increases similarly in both CA1 and CA3: there was a transient increase at 10 min reperfusion 
which returned to control levels for the remainder of reperfusion69. 
In the 2VO/HT model, DeGracia et al90 showed that SGs eventually fuse with protein 
aggregates, showing that Dr. Hu’s model and Dr. DeGracia’s model were not only compatible, 
but that the mechanisms converged.  However, even in this case, there was not a wholesale 
sequestration of any tested ribosome component in the SG/PA hybrid particles. 
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Dr. Hu performed a study of protein aggregates following stroke75, and in this study 
stained brain slices for ribosomal protein S6.  He showed a loss of S6 staining similar to that 
observed in the cardiac arrest model in the Kayali et al study101.  However, SGs were not 
evaluated in this study.  It is of interest to note the loss of S6 staining in the Liu et al study 
because below, in our results with Long Evans rats, we show that of the 14 antigens stained for 
following focal ischemia, all 14 showed loss of staining in the core region. 
C. mRNA Granules 
In a second ribonomic-oriented study using the cardiac arrest model, DeGracia et al 91, 
immuno-mapped eIF4G following global brain I/R.  Here it was observed that in the cytoplasm 
of reperfused neurons, the eIF4G staining took the form of granular “clumps”.  This paper 
suggested that the eIF4G “clumps” might represent degradation products of eIF4G, or possibly 
that eIF4G had been sequestered in the form of the ubi-protein complexes identified by Dr. Hu’s 
laboratory. 
In recent work from our lab, in which I participated, we used fluorescent in situ 
hybridization (FISH) to visualize poly-adenylated mRNAs (pA) in reperfused neurons using a 
poly(T) probe102.  We also performed colocalization studies of pA with a number of antigens by 
double staining with pA FISH and immunofluorescent histochemistry (IF).   
 
Figure 3Figure 3shows the main result of this study.  We observed the pA staining in 
non-ischemic controls (NIC) as diffuse in the cytoplasm.  However, with reperfusion, the pA 
also took the form of granular “clumps” in the cytoplasm, very similar to what was observed 
with eIF4G in the DeGracia et al (2006)91 study.  The granulated form of mRNA in the cell 
cytoplasm we termed “mRNA granules”.   
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Figure 3 : Detection of mRNA 
granules by pA FISH and co-IF 
for 40S, 60S and PABP.   
Left, non-ischemic controls (NIC) 
where the pA and proteins had a 
“smooth” and relatively 
homogeneous staining pattern in 
the cell cytoplasm. Right: 
following 10 min global brain 
ischemia and 1 hr reperfusion, the 
pA staining patterned formed 
granular structures, the mRNA 
granules. The mRNA granules did 
not colocalize with markers of the 
40S and 60S ribosomal subunits, 
but did colocalize with pA-
binding protein (PABP). Images 
adapted from 102. 
 
 
 
 
In the Jamison et al (2008)102 study, the mRNA granules colocalized with eIF4G 
indicating that the eIF4G granulation reported in the DeGracia et al., (2006)91 study were not 
degradation products, but were eIF4G localized in the mRNA granules.  The mRNA granules did 
not colocalize with TIA-1, proving they were not SGs.  They did not colocalize with TTP, a 
marker of processing bodies92, proving they were not processing bodies. The mRNA granules 
did colocalize with HuR, and we therefore believe that the mRNA granules are the HuR granules 
discussed above, which have been described and studied by the Keene Laboratory.  
Most significantly, as shown in Figure 3, when double labeling for pA and S6, a marker 
of the 40S ribosomal subunit, or pA and ribosome P antigen, a marker of the 60S subunit93, was 
performed, the mRNA granules did not colocalize with either antigen.  That is, the mRNA 
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granules did not colocalize with either the 40S or 60S ribosomal subunits. On the other hand, as 
shown in Figure 3, in non-ischemic controls, pA/S6 and pA/RPA strongly colocalized in the 
form of a diffuse cytoplasmic staining.  The Jamison et al102 study also evaluated in vivo 
translation after administration of radioactive amino acids.  The result was obtained that every 
reperfusion time point in which neurons showed the presence of the mRNA granules also 
showed inhibition of in vivo protein synthesis.  Therefore, we now believe that the mRNA 
granules sequester mRNAs away from ribosomes, and that this provides a second mechanism, in 
addition to the cotranslational aggregation model of Dr. Hu, of prolonged TA in reperfused CA1 
neurons.  
In fact, on the basis of the pA staining patterns presented in the Jamison et al study, it 
appears that the pA signal is quantitatively present in the mRNA granules.  This then is the first 
observation of any change in a translational component that: (1) correlates precisely with the full 
time course of TA, and (2) represents a quantitative transformation that would mechanistically 
explain the prolonged TA during reperfusion. 
VIII. Summary and Hypothesis 
To summarize the main points of the background, above it was discussed how a 
prolonged TA correlates exactly with the DND of neurons following both focal and global brain 
ischemia.  Many different mechanisms of prolonged TA have been tested.  Changes in ribosome 
regulation occur mostly at the early reperfusion time points and do not explain the prolongation 
of TA.  Some percent of ribosome components get sequestered in PAs, which can contribute to 
prolonged TA, but cannot fully explain it. To date, the only observation of changes in the 
translational system that is both apparently quantitative and correlates precisely with the time 
course of TA is the observation of mRNA granules following global brain I/R.  It is currently 
unknown if a similar sequestration of mRNA away from ribosomes occurs following focal brain 
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I/R, leading therefore to the main hypothesis of my Dissertation: 
Hypothesis 1 : Focal brain ischemia causes sequestration of mRNA away from 
ribosomal subunits.  
Above it was also discussed how diabetes worsens outcome following brain I/R.  To the 
best of my knowledge, and after a thorough literature review, the translation system in the 
reperfused brain of diabetics has not been studied.  Since TA correlates precisely with cell death, 
and cell death is increased in diabetics, I therefore offer the second main hypothesis of my 
dissertation: 
Hypothesis 2 : Diabetes worsens the TA associated with focal ischemia to increase 
the amount of cell death. 
IX. Factors Affecting Experimental Designs 
The above hypotheses will be tested by the following experimental strategies.  
1) Determine the formation of mRNA granules in the focal ischemic brain, with and 
without diabetes. 
2) Correlate the extent of mRNA granule formation with the extent of brain cell death in 
the focal ischemic brain. 
The methods utilized to carry out these experimental strategies included (1) an animal 
model of focal brain ischemia based on MCAO, (2) an animal model of diabetes using 
streptozocin (STZ)-induced destruction of pancreatic beta cells, (3) the use of standard staining 
methods to determine the extent of necrotic infarcts by the lack of brain slice staining with the 
compound 2,3,5 triphenyltetrazolium chloride (TTC), and (4) detection of pA mRNAs via 
fluorescent in situ hybridization, and a determination of their colocalization with a variety of 
protein antigens via immunofluorescent histochemistry.   Before proceeding to Methods and 
Results, some further rationalization of the Experimental Designs is in order. 
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A. Transient or Permanent Focal Brain Ischemia. 
Below we describe the use of the MCAO model of focal brain ischemia.  Unlike the 
global ischemia models used routinely in the lab, MCAO results in an incomplete ischemia, 
meaning that cerebral blood flow is never reduced to zero.  Even during the ischemic period in 
which the filament blocks the MCA, the remainder of the brain blood flow is normal and 
intrinsic brain and vascular reflexes are activated to enhance blood flow to the MCA territory via 
collateral anastomoses, creating a complex and only partially understood blood flow gradient124.   
Thus, blood flow in the occluded territory during the ischemic period of MCAO can range from 
between 20-50% normal117, which itself is animal strain dependent (see below). 
In contrast, with models of global brain ischemia, there is a discreet and well-defined 
period of zero blood flow (the ischemic period) followed by discreet periods of reperfusion.  
Also, the onset of ischemia and subsequent onset of reperfusion are often rapid.  Thus, the 
ischemic insult with global models can be thought of as a square wave.  But a similar logic does 
not hold for the MCAO focal model. 
These considerations are important with respect to the translational system as follows.  In 
global models, where blood flow is zero during ischemia, intracerebral ATP levels also go to 
zero, and ATP dependent processes come to a halt.  The phosphorylation of the alpha subunit of 
eIF2 requires ATP as a substrate.  Thus, in global models of brain ischemia there is no 
phosphorylation of eIF2 during the ischemia period64; this phosphorylation event occurs within 
the first minutes of reperfusion after ATP levels have increased enough to allow it to proceed.  
On the other hand, in a study by Wulf Paschen’s lab, the levels of eIF2(P) were observed to be 
at their maximum at the end of a 2 hr period of MCAO2.  During the subsequent reperfusion 
period the levels of eIF2(P) decreased from this maximum and returned to pre-ischemic 
30 
 
(control) levels by 6 hr reperfusion.  Thus, the focal case is much different from the global case 
with respect to the phosphorylation of eIF2, which is a key event in the regulation of translation 
in neurons following I/R. 
Therefore, the logic of our study design is different from a typical study using a global 
ischemia model that would use a fixed time of ischemia (usually 10 min) followed by a time 
course of reperfusion.  Because the “ischemic” period in an MCAO model is actually a complex 
mix of ischemia and reperfusion occurring in the same brain, the main focus of the studies we 
shall describe involve what is (perhaps not so accurately) called “permanent” focal ischemia, in 
which we will evaluate increasing durations of MCAO.  We feel this is a necessary set of studies 
to perform before any attempt to perform a fixed value of ischemia followed by increasing 
durations of reperfusion, or what is commonly referred to as “transient” MCAO.  The use of 
transient MCAO for the major studies reported here (e.g. those involving the Long Evans rat 
strain described in Chapter 3) was used primarily to validate the model by demonstrating 
production of a necrotic infarct. 
B. Rat Strain Effects following MCAO 
There is a substantial literature showing differences in outcome amongst different strains 
of rodents, specifically with the MCAO model94.  For example, a study by Prieto et al (2005)117 
showed statistically significant differences in cerebral blood flow during the MCA occlusion 
period in different rat strains.  In this study, Wistar showed the highest blood flows (average ~ 
50%), Sprague Dawley was intermediate (average ~ 38%), and Long Evans showed the lowest 
blood flows (average ~ 28%).   Why different strains demonstrate different blood flows is not a 
topic we study here.  But it is a factor we attempt to account for by performing our studies on 
two different rat strains:  Wistar and Long Evans.  By using the Wistar strain, we can compare 
our results to previous studies of the effect of diabetes after MCAO95,96,104.  By using the Long 
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Evans strain, we can compare our results to the reported studies of the translation system and the 
mRNA granulation process in post-ischemic brain64-65,90,101-102. 
C. Effect of Anesthetic on Outcome from MCAO 
The effect of anesthetic on outcome following brain I/R is a highly researched area.  
Hundreds of published studies have reported that anesthetics can affect outcome either to the 
positive or negative.  It is interesting to note, however, that, as with every other agent that has 
shown laboratory neuroprotection, the ostensible neuroprotective properties of anesthetics has no 
bearing at all on clinical anesthesia in a practical clinical setting97.  The common inhalation 
anesthetic halothane was used for the majority of studies reported here.  However, in my initial 
work with the Wistar strain, some experimental groups were performed using the also common 
combination of the dissociative anesthetic ketamine and the muscular relaxant xylazine.  I report 
these results below even though no significant differences were observed. 
X. Overview of Experimental Plan 
Given the above considerations, the overall experimental plan is illustrated in Figure 4. 
The general plan was that experimental groups were performed, from which tissue slices were 
made and then stained to detect either the infarct (TTC) or molecular markers.  Specific designs 
and analytic methods are reported in subsequent chapters.  The different experimental groups are 
illustrated schematically in Figure 4 and broken out into three categories: (1) animals strain 
(Wistar vs. Long Evans), (2) type of focal ischemia (transient vs. permanent), and anesthetic 
used (ketamine/xylazine (K/X) vs. halothane).  The main experimental groups, all of which used 
halothane anesthetic are listed in Table 1.  The following chapters describe the Methods and 
Results as follows: Chapter 2 describes the Wistar strain studies; Chapter 3 describes studies 
with untreated Long Evans rats, and Chapter 4 describes the studies with diabetic Long Evans 
rats.  Chapter 5 will then discuss the integrated results. 
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Focal brain ischemia
Perfusion fix/tissue slices
Stain tissue
Analyze results
• Wistar vs. Long Evans
• Permanent vs. transient MCAO
• ketamine/xylazine vs. halothane
• TTC
• pA FISH – mRNA granules
– map 3D distribution
– co-stain with 14 protein antigens
 
 
Figure 4: Overview of Experimental Designs 
 
Table 1: Experimental Groups Overview, including number of animals per group (n). 
Strain Ischemia Reperfusion Group name 
Wistar 2 hr - 2I 
(n = 3/grp) 2 hr 4 hr 2I/4R 
 2 hr 24 hr 2I/24R 
 2 hr 7 days 2I/7dR 
    
Long Evans 2hr - 2I 
(n = 5/grp) 2hr 24 hr 2I/24R 
 4 hr - 4I 
 6hr - 6I 
 8hr - 8I 
    
Long Evans 0.5 hr - 0.5I 
Diabetic 1hr - 1I 
(n = 4/grp) 4 hr - 4I 
 6hr - 6I 
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CHAPTER TWO: Studies on Wistar Strain - Methods and Results 
I. Rationale 
Since my 2nd major hypothesis sought to evaluate the effect of diabetes on the translation 
components, I began my work by evaluating the Wistar rat strain so I could compare to previous 
studies of diabetes and focal brain ischemia95,96,104.  Specifically, the 2005 study of Rizk, Rafols 
and Dunbar104 provided the starting point for my investigations.  This study showed that 2 hr 
transient MCAO plus 24 hr reperfusion did not generate an infarct in non-diabetics but that 
diabetic animals showed a large infarct at this same end point, and that neurons of the diabetic 
brains showed substantial activation of apoptotic pathways before the application of MCAO.  I 
therefore sought to evaluate the same time course of MCAO with and without diabetes.  The 
intent of the studies described in this Chapter was to first establish a baseline of mRNA granule 
formation along a time course of transient MCAO in non-diabetic Wistar rats, and then repeat the 
studies using diabetic animals. 
To briefly summarize the results of the studies in Wistar rats, I was unable to detect 
mRNA granules at any time point of reperfusion, out to 7 days.  Instead, I observed only a very 
minor formation of mRNA granules at the 2 hr ischemia-only time point.  We considered that the 
negative result may have been due to two factors.  First, it may be been an anesthetic effect. 
Second, we considered that at 2 hr MCAO, the small number of mRNA granules detected 
reflected either the beginning or end of a time course, and that more mRNA granules might be 
identifiable at either earlier or later ischemia durations.  I therefore conducted a series of studies, 
shifting from halothane to K/X, and also evaluating various durations of ischemia.  The results of 
these studies were also essentially negative.  Although mRNA granules were sporadically 
detected in the 2 hr MCAO + K/X group, their frequency was not apparently different from the 
halothane group.  In general, the frequency of mRNA granules was much lower than would have 
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been expected from our experience with the global brain ischemia model102. 
Being unable to establish a baseline of mRNA granule formation, studies of diabetes in 
the Wistar strain were not conducted.  It is for these reasons I turned to the Long Evans strain 
and those studies are described in Chapters 3 and 4.  Here I report my observations of low 
frequency mRNA granule formation in the Wistar strain neurons.  Because the frequency of 
mRNA granule formation was so low in the Wistar strain, there is not a comprehensive analysis 
such as described for the Long Evans strain in Chapter 3.  Additionally, because of the link 
between TA and stress responses, I stained to determine if the Wistar rats translated HSP70 
protein during the reperfusion time course. 
II. Materials 
HuR primary antiserum was purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, 
CA).  Rabbit polyclonal anti-PABP was purchased from Abcam (Cambridge, MA).  Mouse 
monoclonal ribosomal protein S6 was purchased from Cell Signaling (Danvers, MA).  HSP70 
antiserum was from Stressgen (Ann Arbor, MI).  Alexa FluorR 488 donkey anti-goat IgG, Alexa 
FluorR 555 donkey anti-rabit IgG and Alexa FluorR 555 anti-mouse IgG, used for IF 
histochemistry were purchased from Molecular Probes (Eugen, OR).  A 5’ biotinylated 50-mer 
oligo-dT probe used for FISH was made by Integrated DNA Technologies, Inc. (Coralville, IA).  
Prehybridization and hybridization buffers were obtained from the mRNA locator In Situ 
Hybridization Kit (Ambion, Austin, TX).  TTC was purchased from Sigma-Aldrich (St. Louis, 
MO). 
III. Methods 
A. Animal Model 
All animal experiments were approved by the Wayne State University Animal 
Investigation Committee and were conducted following the Guide for the Care and Use of 
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Laboratory Animals (National Research Council, revised 1996).  Every effort was made to 
minimize animal suffering and the total number of animals used.  Unilateral focal brain ischemia 
was induced in male Wistar rats (weight 275-300g; Harlan, Indianapolis, IN) using the MCAO 
intraluminal suture model of Hatashita et al98. The experimental groups, anesthetic, and number 
of animals per group is shown in Table 2: 
Table 2: Experimental groups and anesthetic for studies of Wistar rat strain. 
Experimental group anesthetic n Ischemia duration Reperfusion duration 
2I halothane 3 2 hr 0 
2I/4R halothane 3 2 hr 4 hr 
2I/24R halothane 3 2 hr 24 hr 
2I/7dR halothane 3 2 hr 7 days 
0.5I K/X 3 ½  hr 0 
1I K/X 3 1 hr 0 
1.5I K/X 3 1 ½  hr 0 
2I K/X 3 2 hr 0 
4I K/X 3 4 hr 0 
Anesthesia was initiated with either a single intraperitoneal (IP) injection of 0.25 ml/kg 
and 0.8 ml/kg K/X or 5 % halothane and maintained with 1.5 % halothane via facemask for the 
duration of the surgery.  Animals were supine and core body temperature was maintained at 37 ± 
0.5˚ C by a homeostatic blanket system (Harvard Apparatus) using a rectal thermometer.  Rats 
were maintained normothermic during the entire surgery period.  After shaving the cervical 
region and cleansing the area with betadine, a midline cervical incision was made in order to 
expose the omohyoid and sternomastoid muscles, which were separated using a retractor to 
expose the right common (CCA) and its bifurcation.  The right CCA was dissected free of 
surrounding tissue and nerves.  All branches of the external carotid artery (ECA) were isolated 
and coagulated.  The CCA was clamped using a vascular clip and the internal carotid artery 
(ICA) was isolated and also clamped.  Under an operating scope, a small cut was made in the 
ECA and a nylon filament ~ 18.5 mm in length was inserted into the CCA and secured.  The 
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vascular clip was then removed from the ICA and the stump of the ECA was transected in order 
to facilitate maneuvering of the nylon filament into the ICA.  The filament was carefully passed 
up into the lumen of the ICA, blocking the MCA at its origin.  Laser Doppler flowmetry (LDF) 
from the ipsilateral cortex, at a coronal level approximately 1 mm anterior to Bregma was used 
to confirm a reduction in blood flow.  Once the LDF readings stabilized, the vascular clip was 
removed from the CCA and all incisions were closed.  Rats were then returned to their cages and 
allowed to recover.  Upon regaining consciousness, rats displayed paresis of the left forelimb and 
unilateral circling.   
B. 2,3,5 Triphenyltetrazolium Chloride Staining  
Immersion staining of TTC was used to measure tissue viability and evaluate infarct size.  
The principle of TTC staining relies on the oxidation of the tetrazolium salt by intact 
mitochondrial dehydrogenase into a red, lipid-soluble formazan, which yields the carmin red 
product, formazan99.  Viable tissue therefore stains deep red, whereas infarcted (necrotic) tissues 
lack dehydrogenase activity and therefore do not stain. Thus, the infarcted area (white) can be 
easily distinguished from the surrounding intact tissues99-100.  At the appropriate times, the rats 
were decapitated, the brains rapidly removed, and placed in ice cold 0.9% NaCl for 5 minutes.  
The brains were then sectioned into 2 mm thick coronal sections using a brain matrix and then 
placed in a 2% solution of TTC in 0.9% NaCl, covered and allowed to incubate for 30 minutes at 
37 ˚C on a shaker.  At the end of the incubation period, the sections were removed and placed in 
4% paraformaldehyde (PFA) at 4˚C for post-fixing.  Digital images of the brain sections were 
taken 48 hours later. 
C. Double-labeling Immunofluorescence and Fluorescent In Situ Hybridization 
At the end of the permanent ischemia or reperfusion periods, the animals were re-
anesthetized and transcardially perfused with 50 ml of 0.9% sodium chloride followed by 250 ml 
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of 4% PFA in 0.1M PBS at a flow rate of 20 ml/min.  The brains were removed and post-fixed 
overnight in the PFA solution at 4˚C.  Using a vibratome, 50 micron slices through the anterior 
forebrain were obtained and stored at -20˚C in cryostat solution until used.  
IF histochemistry for HSP70 was performed as follows.  Brain slices were washed in 
0.1M PBS for 10 minutes x4 then blocked in 10% normal donkey serum (NDS) in 0.1M PBS 
containing 0.3% Triton X-100 (PBS-TX) solution for 25 minutes, following by washing x3 for 
10 min in 0.1M PBS.  Slices were then immersed in primary antibodies in 1% NDS in PBS-TX 
at room temperature on a shaker overnight.  The following day, slices were washed x3 for 10 
min in 0.1M PBS and then incubated in secondary antibody solution, in the dark, for 2 hours and 
washed again x3 for 10 min in 0.1M PBS.101  HSP70 antiserum was used at a 1:200 dilution. 
Double IF/FISH was performed exactly as described previously102 with poly-T probe at 
50 ng/ml and the following primary antisera dilutions:  1:25, anti-HuR; 1:250, anti-PABP; 1:25, 
anti-S6. Secondary antisera dilutions in 1% NDS in PBS-TX were:  1:300, Alexa 488; 1:300, 
Alexa 555. 
Briefly, Double IF/FISH was performed in a two stage procedure in which the FISH 
procedure was a modification of that described in Bessert and Skoff (1999)103.  The first stage IF 
procedure was as described above.  The second FISH stage was performed under low light 
illumination or in the dark.   At the end of the IF procedure slices were mounted on lysine-coated 
slides.  IF-stained sections were fixed in 3.6 % formaldehyde in PBS for 10 min at room 
temperature and then drained and blotted.  Prehybridization was carried out in a box humidified 
with 50% formamide/4X SSC inside an incubator at 32oC for 3 hr in prehybridization buffer 
(mRNAlocator In Situ Hybridization Kit, Ambion, Austin, TX).   Slides were then incubated 
overnight in the same apparatus in a solution of 50 ng/ml of a 5’-biotinylated 50-mer oligo-dT 
probe (Integrated DNA Technologies, Inc., Coralville, IA), dissolved in hybridization buffer 
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(mRNA Locator In Situ Hybridization Kit).  The next day, all subsequent processing was 
performed at room temperature.  Slides were washed x2 in 2X SSC for 10 min and then 
incubated in 1:500 Alexa 488-labeled streptavidin (S32354, Invitrogen, Carlsbad, California) in 
4X SSC/0.1% Triton X-100 for 60 min.  Slides were then washed once in 4X SSC for 10 min 
followed by incubation in 2X SSC/0.1% Triton X-100 containing 1: 667 of biotinylated goat 
anti- streptavidin (BA-0500, Vector Laboratories, Burlingame, CA) for 60 min.  Slides were 
again washed once in 4X SSC for 10 min and then incubated in 1:667 Alexa 488-labeled 
streptavidin in 2X SSC/0.1% Triton X-100 for 60 min.  Slides were then washed sequentially in 
4X SSC for 10 min and 2X SSC for 10 min, and then coverslipped for viewing.   
Slides were examined on an Axioplan 2 Imaging System (Carl Zeiss, Oberkochen, 
Germany) equipped with an ApoTome.  Excitation at 488 nm and 568 nm, and emission at 518 
nm and 600 nm were used for Alexa 488 (green) and Alexa 555 (red), respectively.  Optical 
sectioning was performed using the X63 oil immersion objective to generate z-stacks as 
previously described101.  Fluorescent micrographs shown in the figures are orthographic 
projections of 2.45 micron z-stacks (7 x 0.35 micron optical sections), unless otherwise stated.  
Validation of antisera staining was previously described101-102. 
IV Results 
A. TTC staining 
As a means to validate the MCAO model and evaluate infarct volume, TTC staining was 
performed on male Wistar rats that underwent 2 hours of MCAO followed by 4 hours, 24 hours 
and 7 days of reperfusion.  2 hours of MCAO did not lead to an appreciable necrotic core, at any 
reperfusion duration, even to 7 days reperfusion (Figure 5).  This finding was consistent with 
previous studies conducted in this strain where no visible infarct was seen with TTC staining, 
following 2 hours of ischemia and 24 hours of reperfusion104. 
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Figure 5:  TTC staining of Wistar rat strain 
following transient focal ischemia. 
Male Wistar rats were subjected to 
normothermic, unilateral MCAO for 2 hours 
of ischemia only (2I), 2 hours of MCA 
ischemia plus: 4 hours of reperfusion (4hR), 
24 hours of reperfusion (24hR)  and 7 days 
of reperfusion (7dR).  Representative 2 mm 
slices arranged anterior (top) to posterior 
(bottom), encompassing the MCAO 
territory which includes the striatum.  
 
 
 
 
 
 
B. Frequency of mRNA granule formation 
Microscopic studies conducted to investigate whether or not mRNA granule formation 
took place following MCAO in the Wistar rat revealed that mRNA granules formed only at a low 
frequency.   Granulation of mRNA was detected in only 2 of the 15 animals tested with K/X and 
2 of the 12 animals tested using halothane (Table 3).  Significantly, for both anesthetics, the only 
experimental group showing mRNA granules was the 2 hr MCAO ischemia group. mRNA 
granules were not detected in any reperfused samples.  The use of the injectable anesthetics 
ketamine and xylazine or the inhalational anesthetic halothane had no effect the outcome 
remained the same.  With respect to the experimental groups, therefore, the frequency of mRNA 
granule formation was 67% for both the K/X and halothane 2 hr MCAO groups, and zero for all 
other groups.  Wistar rats, in general, have been shown to be more resistant to ischemic insults 
40 
 
when compared to other strains with comparable physical and physiologic parameters105,106.  The 
lack of mRNA granule formation in this instance, consistent with the TTC staining result, 
indicates the Wistar strain did not experience a severe enough ischemic insult to induce mRNA 
granulation. 
Table 3:  Frequency of mRNA granule formation in the Wistar rat following MCAO.   
Anesthetic total n n with mRNA granules 
K/X 15 2 (13.3 %) 
halothane 12 2 (16.7 %) 
Animals were tested using either ketamine/xylazine (K/X) or halothane anesthesia. 
Error! Not a valid bookmark self-reference. Figure 6: Distribution of mRNA granule containing neurons in Wistar rats at 2 hr MCAO. 
C. Histological assessment of mRNA granules in Wistar rats 
In spite of their low frequency of occurrence, I assessed the mRNA granules in the 2I 
Wistar rat group to determine if their colocalization 
properties were similar to that observed following global 
brain ischemia.  In the four samples displaying neurons 
containing mRNA granules, these neurons were sparsely 
scattered in clustered areas on the ipsilateral hemisphere as 
shown in Figure 6.  A crude estimate would put their area 
to be less than 5% of the total hemispheric area, and they 
tended to be more medially located in the ipsilateral 
hemisphere.   
Figure 7, panels A, B and C, show 
photomicrographs of mRNA-granule containing neurons 
co-stained with pA FISH and IF for S6, PABP and HuR, respectively.  For each co-staining pair, 
sham operated non-ischemic control (NIC) animals are shown along with the 2I samples.  The 
first column is the merged image, the second column the pA channel (green) and the third 
Figure 6 : A rough indication of the 
distribution of mRNA-granule 
containing neurons in Wistar rats at 
2hr MCAO. Green circles indicate 
scattered areas where the neurons 
showed mRNA granulation. The dark 
red area is where a necrotic core 
would be expected based on the MCA 
territory, and the surrounding light red 
area represents where penumbra is 
expected.
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column is the respective red channel for the protein antigen.   
Figure 7A shows pA/S6 staining in layer II cerebral cortical neurons. The NIC samples 
showed a smooth and homogeneous pattern of pA/S6 colocalization in the cell cytoplasm.  This 
colocalization likely represents normal mRNA-ribosomal association during the protein 
translational process.  Neurons in the ipsilateral region of the 2I sample formed mRNA granules 
that did not colocalize with S6, which is better visualized by observing the separate channels.  In 
the pA channel there is concentration of the pA signal that is not present in the S6 channel.  
Compared to the results of layer II cortical staining I will show in Chapter 3, the amount of 
mRNA granulation in Figure 7A can be considered only partial.   
A more obvious mRNA granulation was apparent in the layer V pyramidal neurons seen 
co-stained with PABP in Figure 7B and HuR in Figure 7C.    For pA/PABP, it is again seen how 
the NIC showed a diffuse cytoplasmic colocalization.  For the 2I sample, both the pA and PABP 
signal show granulation, which colocalize to form yellow mRNA granules in the merged image.  
For pA/HuR (Figure 7C), the mRNA granules were quite obvious compared to NIC samples.  
Although the merged image of pA/HuR does not produce yellow mRNA granules, it can be seen 
that HuR is indeed granulated in the HuR channel of the ischemic but not NIC sample. 
In the Jamison et al (2008) study of mRNA granules in global ischemia, identical patterns 
were seen in which S6 did not, but PABP and HuR did colocalize with the mRNA granules.  
Therefore, in spite of the relatively infrequent occurrence of mRNA granules in the Wistar rat 
strain following focal I/R, the mRNA granules are similar to those discovered following global 
ischemia with regard to colocalization with these three antigens. 
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Figure 7 : Colocalization studies of mRNA granules with S6, PABP & HuR in 2hr MCAO 
Wistar rats. 
(A) pA/S6 in layer II of cerebral cortex, (B) pA/PABP in layer V or cererbral cortex, (C) 
pA/HuR in layer V of cerebral cortex.  Merged images, pA green channel and protein antigen red 
channels as indicated.  Scale bars apply to each respective row. 
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D. “Intermediate” pA phenotypes of some layer V neurons 
As seen in Figure 7C, the layer V neurons showed distinctly identifiable mRNA granules 
in the 2I samples.  However we occasionally observed a phenotype that appeared “intermediate” 
between fully granulated mRNA as seen in Figure 7C and the relatively smoother pA signal in 
the cytoplasm of NICs.  The rarity of these “intermediate” neurons made systematic study of 
them implausible and I simply note and record their occurrence 
here.
ipsilateral
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LVipsilateral Linear weighted averaging
merge
poly(A)
S6
1
2
3
4
3
 
Figure 8 illustrates two of these layer V pyramidal neurons each of which displayed a 
prominent ridge-like pA staining pattern, which was not present in the S6 channel.  The “ridges” 
appeared as either perinuclear or as tracks that appeared to run along the plasma membrane and 
apical dendrite.  
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For the neuron in the first column of Figure 8, a “deep stack” of 37 optical sections with a 
z-depth of 13 microns was acquired.  This z-stack was volumetrically rendered using a method 
called linear weighted averaging (LWA) to better visualize the pA staining pattern of the cell.  
LWA is a non-transparent method of superimposing the optical sections that allows 3D 
structures such as the ridge-like structures along the nucleus (arrow labeled 1) and plasmalemma 
of the apical dendrite (arrows labeled 2) to be more readily seen.  Additionally, a reticulated 
structure (arrow labeled 3) was prominently visible; at this same location in the cell there was no 
staining at all for ribosomal protein S6 (arrow labeled 4).  Again, the relative rarity of these 
prevented any type of systematic study.  In Chapter 3, where systematic colocalization studies 
are performed with the mRNA granules, I found these did not colocalize with markers of the 
endoplasmic reticulum, Golgi apparatus, microtubules or intermediate filaments, and it is possible 
the ridge-like structures identified here would also not colocalize with these structures. 
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Figure 8:  Layer V neurons with an “intermediate” pA phenotype in Wistar rats.  
First and second columns show single layer V neurons containing “ridge-like” pA structures that 
are not present in the S6 channel.  Third column shows a 3D reconstruction of the neuron in the 
first column using linear weighted averaging volume rendering that enhanced the visibility of the 
pA structures. 
E. HSP70 immunostaining 
The heat shock response is a well-documented stress response that occurs in cells 
following perturbations in its environment.  HSP70 protein belongs to the family of heat shock 
proteins that are upregulated when a cell is stressed.  Previous studies have shown that hsp70 
mRNA and HSP70 protein are upregulated primarily in endothelial cells of large blood vessels 
following MCAO ischemia107 and that the upregulation of its translation correlates with the 
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colocalization of HuR with mRNA granules102. Additionally, translation of HSP70 has been 
shown to be a protective response following brain I/R108.  Given that Wistar rats did not form an 
infarct at any time point tested (Figure 5), I assessed the expression of HSP70 protein in order to 
see if there was a correlation with the TTC staining results.   
Following 2 hours of ischemia, HSP70 was expressed in different structures as a function 
of reperfusion duration (Figure 9).  At 4hR, only contractile cells wrapped around the surface of 
endothelial cells known as pericytes stained for HSP70 in the penumbral cortex and striatum.  
The morphology of the pericytes was visualized by 3D reconstruction of z-stacks of HSP70 
staining (Figure 9D).  At 24hR, striatal neurons prominently stained for HSP70.  At 7dR only 
endothelial cells of blood vessels throughout the ipsilateral hemisphere stained for HSP70.  
These results show that a complex pattern of HSP70 expression occurred in the brains of the 
Wistar rats following transient MCAO.  The successful translation of HSP70 protein is consistent 
with the lack of an infarct in the Wistar strain following MCAO. 
 
Figure 9 :  HSP70 protein 
expression in different cell 
types as a function of 
reperfusion duration.  
2 hours of MCAO ischemia 
followed by:  (A) 4 hours 
reperfusion (4hR) only 
showed HSP70 expression in 
pericytes. (B) High 
magnification, 3D 
reconstruction of HSP70 
reveals the characteristic 
morphology of pericytes.   
(C) At 24hR, penumbral 
neurons stained for HSP70 
and (D) at 7dR endothelial 
staining of HSP70 occurred in 
blood vessels. 
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CHAPTER THREE: Studies on Long Evans - Methods and Results 
I. Rationale 
Although the Wistar rat strain evidenced neurons containing mRNA granules following 2 
hr MCAO, and these had characteristics in common with those identified in neurons following 
global brain ischemia102, their frequency of occurrence in both the experimental groups and in 
terms of the area of brain tissue affected was far too small to use as a baseline for studies of the 
effect of diabetes on the translational system following focal brain ischemia.  Since mRNA 
granules had been initially discovered in the Long Evans rat strain102, I undertook MCAO studies 
in the Long Evans rat strain. 
This turned out to be a fortuitous decision because the Long Evans rat strain displayed 
abundant mRNA granulation of neurons in response to focal brain ischemia as I will describe in 
this chapter.  Because the Long Evans gave a positive result with respect to mRNA granule 
formation, I undertook a systematic analysis of their distribution along a time course of ischemia 
duration.  A reperfusion time course was not studied here because it was first necessary to study 
the degree to which mRNA granules formed at different durations of ischemia.  To characterize 
the mRNA granules along a time course of ischemia, three main types of analysis were 
performed: (1) a study of different histological regions in the MCAO brain, (2) a three 
dimensional (3D) study along the rostral-caudal extent of the brain, and (3) a comprehensive 
colocalization analysis of the mRNA granules with two categories of markers: (a) mRNA 
interacting proteins, and (b) markers of subcellular organelles. 
II. Materials 
Table 4 lists the antisera, what they are markers of, vendors and dilutions used in the 
present study. All other antibodies were purchased from companies previously described in 
Chapter 2.  I will briefly describe each marker in the Results section ahead. 
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Table 4: Antisera used for colocalization studies.   
Antisera Marker for Vendor Catalog # Dilution 
-tubulin  microtubules Sigma T6199 1:100 
APRIL HuR ligand Abcam ab4224 1:100 
COX IV mitochondria Abcam ab16056 1:50 
GM130 cis-Golgi apparatus BD Biosciences 610822 1:100 
HuR mRNA BP Santa Cruz sc-5261 1:25 
NeuN nucleus Millipore MAB377 1:500 
NF H/M intermediate 
filaments 
Sigma-Aldrich N2912 1:300 
PDI Endoplasmic 
reticulum 
Thermo Scientific MA3-019 1:200 
pp32 HuR ligand Enzo Life Sciences ADI-905-234-
100 
1:250 
RPA 60S subunit ImmunoVision HPO-0100 1:5000 
S6 40S subunit Cell Signaling 2317 1:25 
TGN38 trans-Golgi apparatus Thermo Scientific MA3-063 1:200 
Abbreviations and a brief description of the antigens is provided in the text. 
A. Animal Model 
Unilateral focal brain ischemia was induced in male Long Evans rats (weight 275-300g; 
Charles River Laboratories International, Inc., Wilmington, MA) using the same model of 
MCAO described in Chapter 2.   The experimental groups and number of animals used are listed 
in Table 5. 
Table 5: Experimental groups used in Long Evans studies. 
Experimental Group Ischemia Reperfusion n 
Sham controls - - 3 
2I 2hr - 5 
2I/24R 2hr 24 hr 5 
4I 4 hr - 5 
6I 6hr - 5 
8I 8hr - 5 
III. Methods 
A. TTC Staining 
TTC staining was performed as previously described in Chapter 2.  
B. Immunofluorescence and FISH 
Double IF/FISH was performed exactly as described in Chapter 2.  Primary antisera 
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dilutions are listed in Table 4.  Secondary antisera dilutions in 1% NDS in PBS-TX were the 
same as that previously described in Chapter 2. 
C. Systematic histological analysis of MCAO brain 
As described in Chapter 1, focal ischemia results in heterogeneous damage in the brain 
producing, at minimum, a core, penumbra, and the remaining nonischemic brain tissue.  
Therefore, for all samples, each of these regions was analyzed.  In addition, since the MCA feeds 
both the cerebral cortex and striatum, I evaluated both regions histologically.  The rat cerebral 
cortex, while functionally six layered, shows 3 anatomical demarcations at the coronal levels I 
investigated (around 1 mm anterior to Bregma).  Layers II and III form one large layer most 
proximal to the brain surface, under which are layers V and then VI.   Thus, I routinely analyzed 
4 histological regions: striatum, and layers II/III, V, and VI.  In total, to systematically study the 
brain after focal ischemia, for every experimental animal I routinely photographed from the 12 
different areas in a given coronal section.  The different MCAO-induced areas and histological 
regions are illustrated in Figure 10. 
 
Figure 10: Regions systematically analyzed in Long Evans MCAO brains.  
Histological regions are listed on the left of the coronal section, and MCAO-induced areas are 
displayed on the right hemisphere.  The coronal section used for analysis of histological regions 
was at approximately 1 mm anterior to Bregma. Purple area in sagittal inset shows the rostral-
caudal extent used for 3D reconstructions described in section IV.D below.  Images adapted and 
modified from109. 
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D. Volumetric reconstruction of pA staining 
For computer reconstructions of the 3D rostral to caudal spatial distribution of neurons 
containing mRNA granules, sixteen coronal slices, 100 microns apart, were evaluated between 
approximately 1.32 mm to – 0.60 mm anterior to Bregma, containing the MCA territory.   
Slices were stained by double labeling with pA FISH and PABP IF.  Areas with mRNA 
granules-containing neurons and areas with shrunken/distorted neurons (described in Results 
below) were determined for each slice under 20X magnification and marked on photocopies of 
corresponding coronal sections taken from the Paxinos and Watson Rat Brain Atlas109.  Since 
PABP strongly colocalizes with mRNA granules102, all mRNA granule-containing regions were 
confirmed by inspection under the 40X objective for both pA and PABP stains.  Determination 
of areas containing neurons with either mRNA granules or with shrunken/distorted neurons was 
conducted by two independent observers blinded to the identity of the experimental groups; the 
independent mappings generally agreed to > 90%. 
Hand-drawn images were then digitized as BMP files on a flat bed scanner and imported 
into Amira 5.2.0 (Visage Imaging, San Diego, CA, USA) to perform 3D reconstructions.  The 
mRNA granule-containing and shrunken/distorted neuron-containing areas were traced onto 
cross sections at approximately the same Bregma coordinates of the corresponding images of the 
digital rat brain dataset from the Laboratory of Neuro Imaging (LONI) from the University of 
California at Los Angeles110.  The LONI dataset used was the series of coronal images through 
the entire rat brain sampled at 30 micron intervals and digitized at 1024 x 1024 pixels, 8 bit 
resolution. (This data is available for download at: www.loni.ucla.edu/Atlases/Atlas_ 
Detail.jsp?atlas_id=1) 
For both illustration purposes and for quantitation (described below) the 3D reconstructed 
volumes were embedded within the LONI dataset.  The LONI dataset was masked to include 
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only the brain, and volumetrically rendered in Amira from slice (using the exact file names of the 
LONI dataset) cor_0979.gif (at Bregma -0.66 mm) through slice cor_1043.gif (at Bregma +1.34 
mm) using the Voltex method with ‘mip’ (mean intensity projection) and ‘color table’ options 
selected, and a constant color of RGB = (0.894, 0.894, 0.894). 
From the 16 sequential brain sections of FISH/IF staining, 3D volumes were generated in 
Amira 5.2.0 as per user manual instructions.  Two volumes were constructed per each 
experimental animal: the volume containing shrunken/distorted neurons (colored red in the 
figures and labeled “core”) and the volume of mRNA granule-containing neurons (colored green 
in the figures and labeled “granular”).  Magnitudes of each volume were taken as the number of 
voxels contained in each volume as calculated by built-in Amira routines.  The “total volume” 
was taken as the number of voxels in one hemisphere of the masked LONI dataset between 
coordinates +1.34 to -0.66 mm anterior to Bregma.  “Total affected volume” was the sum of the 
core and granular voxels in an animal.  Two different percents were calculated to express the 
volumetric data.  Relative percent volume calculated the relative proportions of the core and 
granular volumes occupying the total affected volume.  Absolute percent volume calculated the 
percent of the total LONI dataset volume occupied by the granular and/or core volumes.  
Calculated percents for experimental groups were compared using ANOVA, and Tukey post hoc 
where appropriate, with significance was set at p < 0.05.  Using the pre-core volume as an 
example, the percentage formulas were. 
100# voxels pre- core  
# voxels pre- core + # voxels granular
relative percent x  
100# voxels pre- core 
# voxels in LONI dataset between Bregma +1.34 mm to - 0.66 mm
absolute percent x  
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IV. Results 
A.  TTC staining 
When permanent MCAO (pMCAO) was evaluated out to 8 hr ischemia in the Long 
Evans rats, none of the pMCAO samples showed an infarct by TTC staining (Figure 11).  
However, TTC staining of Long Evans rats showed an infarct in the 2 hr ischemia plus 24 hr 
reperfusion group (Figure 11).  This result contrasts to the Wistar groups, where no infarct was 
seen as far out as 7 days of reperfusion (Figure 5). 
The 2I/24R TTC result provided a rough guide to our use of the terms “penumbra” and 
“core” in the 3D reconstructions described below.  In the pMCAO ischemia-only samples, 
neurons located in the areas devoid of TTC staining in the 2I/24R samples generally had a 
shrunken and distorted appearance, and often had weak staining for protein antigens.  Therefore, 
in spite of TTC staining the pMCAO brains from 2 to 8 hr ischemia-only, the neurons displayed 
characteristics that are not revealed by TTC, but can be detected by other stains111, and are 
indicators of damaged neurons that will eventually form the core of the infarct. 
 
 
 
 
 
Figure 11:  TTC staining in Long Evans rats subjected to 
MCAO ischemia.   
Representative 2mm thick brain slices are arranged 
anterior (top) to posterior (bottom) and encompass the 
MCAO territory, which includes the striatum. 
 
 
 
 
sham     4I        8I       2I/24R
Long Evans
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B. Frequency of mRNA granule formation 
The total number of experimental Long Evans rats showed a much higher frequency of 
mRNA granule formation (80%) (Table 6) than the total number of experimental Wistar animals 
(11%) (Table 3).  However, this is a misleading number because the experimental groups are not 
directly comparable in terms of the total number of rats. The Wistar set consisted mainly of 
transient MCAO, whereas the Long Evans set was mainly pMCAO.  When compared in terms of 
experimental groups, the Wistar and Long Evans had comparable frequencies: 67% of 2I Wistar 
rats and 100% of the pMCAO groups of Long Evans rats had mRNA granules in some neurons.   
We will see below, however, that the affected areas were much larger in the Long Evans strain. 
 
Table 6:  mRNA granule frequency in Long Evans rats. 
Experimental Group n tested n w mRNA granules Percent 
2I 5 5 100 % 
2I/24R 5 0 0% 
4I 5 5 100 % 
6I 5 5 100 % 
8I 5 5 100 % 
total 25 20 80% 
C. Systematic histology of mRNA granules in Long Evans MCAO 
Co-staining pairs of pA FISH with IF for S6, PABP and HuR were performed across the 
12 areas illustrated in Figure 10.  Three co-stains were performed per animal to compare to both 
the Wistar results that used these stains and to compare to the previous work on global ischemia 
in the Jamison et al. study102.  There were two main questions I wanted to ask with these studies: 
(1) Did mRNA granules form preferentially in any of the four histological regions: layer II/III, 
layer V, layer VI and striatum?  (2) Did mRNA granules form preferentially in any of the three 
major MCAO-inducing brain areas: core, penumbra and (non-ischemic) contralateral 
hemisphere?  Representative samples for layers II/III and V are shown in Figure 12, and for layer 
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VI and striatum in Figure 13. The samples shown are drawn mainly from the 2I and 4I groups. 
The results to emerge from these studies are: (1) neurons of all 4 histological regions, 
layers II/III, V, VI and striatum, formed mRNA granules, (2) the mRNA granule-containing 
neurons were found preferentially in penumbral areas at the watershed between the MCA and 
ACA, (3) their colocalization patterns with S6, PABP and HuR were similar to those seen in the 
Wistar studies described in Chapter 2 and to those seen following global brain ischemia102, and 
(4) shrunken/distorted neurons were present in the core areas fed directly by the MCA. 
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Figure 12: Layers II/III and V: sham, contralateral, penumbral and core pA & S6, PABP or HuR 
merged images.  Scale bars in lower right panel apply to all panels for a given histological 
region. 
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Figure 13: Layer VI and striatum: sham, contralateral, penumbral and core pA & S6, PABP or 
HuR merged images. Scale bars in lower right panel apply to all panels for a given histological 
region. 
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In addition, the core neurons generally had a weaker staining for the protein antigen, but 
the pA staining was good enough to discern the shape of the shrunken and/or distorted neurons.  
Finally, in general, the neurons of the four histological regions on the contralateral side 
resembled sham operated controls. 
With regard to the colocalization patterns, in sham and contralateral neurons, S6 and 
PABP formed diffuse colocalization.  When neurons showed mRNA granules, S6 did not, but 
PABP and HuR did colocalize with the mRNA granules.  The colocalization with HuR was 
strong enough to form distinctly yellow mRNA granules, unlike the Wistar strain, but similar to 
CA3 following global brain ischemia102. 
D. 3D Volumetric analysis 
The above colocalization studies showed that neurons in all cortical layers and the 
striatum could form mRNA granules, but there was quite a bit of variance in the distribution of 
the granules amongst these regions.  3D volumetric reconstructions were generated as a means to 
determine the relative distributions of neurons containing mRNA granules in the various regions.  
The reconstructions also served to assess the extent of the ischemic insult through a rostral to 
caudal extent in the brain. 
A representative series of cross sections used to generate the 3D reconstruction of a 4I 
sample is shown in Figure 14.  The top panels illustrate the appearances of areas assigned as 
either granular penumbra or shrunken/distorted core verses normal appearing, using the pA 
FISH/PABP IF co-staining of layer II cortical neurons.  The bottom panel of Figure 14 shows an 
example of a 4I animal where mRNA-granule containing (green areas) and shrunken and 
distorted neurons (red areas) appeared in rostral-caudal cross sections.  These areas are shown 
superimposed on the corresponding slices from the LONI rat brain dataset.  Only half the dataset 
used for volumetric reconstruction is illustrated in the figure, therefore each slice is separated by 200µ. 
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Figure 14:  Cross-sections used for 3D reconstructions in Long Evans strain after pMCAO. 
Top: Example appearances of normal, granular and core areas in layer II. Scale bar on right panel 
applies to all three panels of the top row. Bottom: Rostral to caudal cross-sections show the 
extent of the granular penumbral (green) and core (red) areas through the MCA territory of a 
representative 4I samples. 
For this particular example, no striatal neurons showed evidence of mRNA granules.  The 
cells of the lateral striatum were shrunken and distorted, appearing similar to the top panel 
marked “core”.  Neurons of the medial striatum had the same appearance as contralateral and 
sham-operated striatal neurons (e.g. as in Figure 13).   This animal also showed a substantial 
fraction of cerebral cortex to have a core phenotype that ran for some distance across all the 
cortical layers, mainly in somatosensory cortex.  However, significant areas of cerebral cortex 
contained neurons expressing cytoplasmic mRNA granules.  These areas were mostly medial to 
the core cortical areas, and were in the watershed area between the MCA and anterior cerebral 
artery territory. 
Using the sequential cross sections, 3D volumes for the penumbra and core phenotypes 
over a range of pMCAO durations were generated (Figure 15).  Quantitative analysis of the 
volumes for the 3D reconstructions from the pMCAO groups are as follows:  at 2hrI, 72.8 ± 
38.5% of the affected volume had mRNA granule containing neurons, and 27.2 ± 38.5% 
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contained distorted and shrunken cells.  However, the relative volume percents did not clear 
statistically.  There was a drop in the relative proportion of the affected volume of neurons 
containing mRNA granules to 15 ± 11.2%, 8.6 ± 8.0% and 0 % for the 4hrI, 6hrI and 8hrI groups 
respectively, and corresponding increases for the volume of core neuron phenotypes.  The 
relative percents for the 4I and 6I groups cleared statistically (ANOVA p < 0.05, Tukey p < 
0.05).  An exponential curve fit of the decrease in relative volume containing mRNA granules 
(Figure 15, blue curve) gave a correlation coefficient (cc) equal to 0.91, whereas a linear fit gave 
a cc of 0.77 (Figure 15, magenta curve).  The exponential drop in mRNA granule-containing 
neuron volume corresponds to expansion of the core into the penumbral region124, as ischemia 
duration increases. 
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Figure 15:  Quantification of mRNA granule-containing volumes in Long Evans pMCAO rats. 
Left: Representative 3D reconstructions from 2, 4, 6 and 8 hr of pMCAO in Long Evans rats.   
Right: Plot of percent affected volume occupied by mRNA granule-containing or core-like 
neurons.  Blue curve is an exponential fit through the penumbral percents, and magenta curve is 
a linear fit. The correlation coefficients (cc) of the respective fits are indicated.  There was a 
statistically significant difference (post hoc p < 0.05) for the relative percents of penumbra and 
core at the 4 hr and 6 hr experimental groups. 
E. Colocalization in Layer II neurons 
In this study, layer II/III mRNA granule forming neurons were assessed for 
colocalization with markers of organelles (Figures 16-22) and mRNA binding proteins (Figures 
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23-28).  Figures 16-28 show staining in the three main MCAO regions: contralateral, penumbral 
and core, the latter two terms used as above.  For these studies the results are shown in terms of 
the merged green and red channel and underneath are the individual green and red channels so 
the patterns of staining in the individual channels can be directly inspected along with the 
merged images.  A summary of the staining patterns of the 13 antigens in the contralateral 
neurons and with the mRNA granules is provided in Table 7.  
1. Double IF/pA FISH and Intracellular Organelle markers 
For the contralateral, nonischemic hemisphere, the only organelle marker to show some 
degree of colocalization with pA mRNAs was protein disulfide isomerase (PDI, Figure 16), an 
endoplasmic reticulum (ER) localized enzyme used in the formation of disulfide bond.  This is 
not unexpected, and the overlap of pA and PDI likely reflects the detection of rough ER, in 
which ribosomes are localized on the surface of the ER membrane.  This would bring mRNA 
into close physical proximity to enzymes such as PDI. 
However, in the penumbral neurons, the mRNA granules did not colocalize with PDI 
(Figure 16), GM130 (Figure 17) or TGN38 (Figure 18).  GM130 is a 130 kDa “Golgi marker” 
protein localized to cis-Golgi. The 38 kDa trans-Golgi network marker localizes the trans-Golgi.  
The lack of colocalization indicates mRNA granules are not associated with the internal 
membranes making up the proximal secretory apparatus of the cell.  The mRNA granules did not 
colocalize with cytochrome c oxidase, subunit IV (COX IV), an inner mitochondrial membrane 
protein involved in electron transport (Figure 19).  Nor did they colocalize with α-tubulin (Figure 
20) or with an antisera that detects the heavy (H) and medium (M) weight neurofilament proteins 
(NH-H/M, Figure 21) and thereby do not interact with microtubules or neuronal intermediate 
filaments, respectively.  Unexpectedly, the mRNA granules did colocalize with the widely used 
neuronal marker, NeuN (Figure 22).  “NeuN” is an abbreviation of “neuronal nuclei”, and I used 
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this antiserum as a nuclei marker.  However, we were surprised to observe the NeuN signal 
clearly colocalized with the mRNA granules outside of the nucleus.  In sum, these results 
indicate that mRNA granules do not associate with the organelle markers tested.    
2. Double IF/pA  FISH and mRNA binding proteins 
In the non-ischemic contralateral neurons, the one mRNA binding protein that strongly 
colocalized with cytoplasmic pA was ribosome p antigen (RPA, Figure 23) a marker of the large 
60S ribosomal subunit112.  Similar to S6, such colocalization would be expected to reflect mRNA 
associated with translating ribosomes.  The only other markers that showed colocalization with 
pA in the contralateral neurons were TIA-1 and pp32.  This colocalization occurred in the form 
of small punctate spots in the cytoplasm.  Based on Foaz Kayali’s work101, we now know the 
TIA-1/pA spots in the cytoplasm are stress granules.   
For the penumbral layer II neurons, the mRNA granules did not colocalize with RPA just 
as they did not colocalize with S6 (e.g. see pA/S6 co-stains in Figure 12 and Figure 13).  Thus, 
the mRNA granules are sequestered away from the entire ribosome, both 40S and 60S subunits. 
The mRNA granules colocalized with HuR, an mRNA binding protein (Figure 24), but did not 
colocalize with the HuR cofactors APRIL and pp32 (Figures 25 and 26, respectively).  ARPIL 
and pp32 are involved in the nuclear to cytoplasmic mRNA transport function of HuR113.  The 
mRNA granules did not colocalize with the stress granule marker, TIA-1 either (Figure 27), 
ruling out the possibility of being stress granules.  Lastly, there was no colocalization of the 
mRNA granules with TTP, an mRNA destabilizing protein that is associated with degradative 
processing bodies.114  Based on the results here, mRNA granules that form following focal 
ischemia behave the same as those that occur following global ischemia102, binding well-known 
mRNA binding proteins and sequestering mRNA away from ribosomal machinery. 
Finally, it is striking that for each antigen studied, there is a decrease in protein antigen 
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staining in core neurons.  Technically, this cannot be due to interference by the poly(T) probe 
because the FISH procedure is performed after the IF procedure.   
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Figure 16:  Layer II colocalization studies in Long Evans for pA & PDI. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and PDI (protein disulfide 
isomerase), a marker of the endoplasmic reticulum (red channel) in layer II of cerebral cortex 
following 2 hrs permanent MCAO ischemia.  Images taken from coronal section approximately 1 
mm anterior to Bregma using the coordinates of Paxinos and Watson (1998).  Scale bar in lower 
right panel is 10 microns and applies to all panels. 
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Figure 17:  Layer II colocalization studies in Long Evans for pA & GM130. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and GM130, a marker of the 
cis-Golgi Apparatus (red channel) in layer II of cerebral cortex following 2 hrs permanent 
MCAO ischemia.  Images taken from coronal section approximately 1 mm anterior to Bregma 
using the coordinates of Paxinos and Watson (1998).  Scale bar in lower right panel is 10 
microns and applies to all panels. 
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Figure 18:   Layer II colocalization studies in Long Evans for pA & TGN38.  
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and TGN38, a marker of the 
trans-Golgi Network (red channel) in layer II of cerebral cortex following 2 hrs permanent 
MCAO ischemia.  Images taken from coronal section approximately 1 mm anterior to Bregma 
using the coordinates of Paxinos and Watson (1998).  Scale bar in lower right panel is 10 
microns and applies to all panels. 
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Figure 19: Layer II colocalization studies in Long Evans for pA & COX IV. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and COX IV (cytochrome c 
oxidase, subunit 4), a marker of the mitochondria (red channel) in layer II of cerebral cortex 
following 2 hrs permanent MCAO ischemia. Images taken from coronal section approximately 1 
mm anterior to Bregma using the coordinates of Paxinos and Watson (1998).  Scale bar in lower 
right panel is 10 microns and applies to all panels. 
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Figure 20:  Layer II colocalization studies in Long Evans for pA & α-tubulin. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and α-tubulin, one of the 
main proteins of the microtubule component of the cytoskeleton (red channel) in layer II of 
cerebral cortex following 2 hrs permanent MCAO ischemia. Images taken from coronal section 
approximately 1 mm anterior to Bregma using the coordinates of Paxinos and Watson (1998).  
Scale bar in lower right panel is 10 microns and applies to all panels. 
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Figure 21:  Layer II colocalization studies in Long Evans for pA & neurofilaments H and M. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and neurofilaments H and 
M (NF-H/M), a marker of the intermediate filament component of the cytoskeleton (red channel) 
in layer II of cerebral cortex following 2 hrs permanent MCAO ischemia. Images taken from 
coronal section approximately 1 mm anterior to Bregma using the coordinates of Paxinos and 
Watson (1998).  Scale bar in lower right panel is 10 microns and applies to all panels. 
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Figure 22:  Layer II colocalization studies in Long Evans for pA & NeuN. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and NeuN, a marker of 
neuronal nuclei (red channel) in layer II of cerebral cortex following 2 hrs permanent MCAO 
ischemia. Images taken from coronal section approximately 1 mm anterior to Bregma using the 
coordinates of Paxinos and Watson (1998).  Scale bar in lower right panel is 10 microns and 
applies to all panels. 
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Figure 23:  Layer II colocalization studies in Long Evans for pA & RPA. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and RPA, a marker of the 
large ribosomal subunit 60S (red channel) in layer II of cerebral cortex following 2 hrs 
permanent MCAO ischemia. Images taken from coronal section approximately 1 mm anterior to 
Bregma using the coordinates of Paxinos and Watson (1998).  Scale bar in lower right panel is 
10 microns and applies to all panels. 
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Figure 24: Layer II colocalization studies in Long Evans for pA & HuR. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and HuR, an mRNA 
binding protein that stabilizes adenine and uridine rich element (ARE)-containing mRNAs, in 
layer II of cerebral cortex following 2 hrs permanent MCAO ischemia.  Images taken from 
coronal section approximately 1 mm anterior to Bregma using the coordinates of Paxinos and 
Watson (1998).  Scale bar in lower right panel is 10 microns and applies to all panels. 
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Figure 25: Layer II colocalization studies in Long Evans for pA & APRIL. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and APRIL (acidic protein 
rich in lysine), a HuR accessory protein (red channel) in layer II of cerebral cortex following 2 
hrs permanent MCAO ischemia.  Images taken from coronal section approximately 1 mm 
anterior to Bregma using the coordinates of Paxinos and Watson (1998).  Scale bar in lower right 
panel is 10 microns and applies to all panels. 
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Figure 26: Layer II colocalization studies in Long Evans for pA & pp32. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and pp32 (red channel), a 
HuR accessory protein involved in mRNA nuclear export in layer II of cerebral cortex following 
2 hrs permanent MCAO ischemia.  Images taken from coronal section approximately 1 mm 
anterior to Bregma using the coordinates of Paxinos and Watson (1998).  Scale bar in lower right 
panel is 10 microns and applies to all panels. 
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Figure 27: Layer II colocalization studies in Long Evans for pA & TIA-1. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and TIA-1 (red channel) , a 
canonical component of stress granules in layer II of cerebral cortex following 2 hrs permanent 
MCAO ischemia.  Images taken from coronal section approximately 1 mm anterior to Bregma 
using the coordinates of Paxinos and Watson (1998).  Scale bar in lower right panel is 10 
microns and applies to all panels. 
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Figure 28:  Layer II colocalization studies in Long Evans for pA & TTP. 
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and TTP (red channel), an 
enzyme involved in mRNA degradation and localized to processing bodies,  in layer II of 
cerebral cortex following 2 hrs permanent MCAO ischemia.  Images taken from coronal section 
approximately 1 mm anterior to Bregma using the coordinates of Paxinos and Watson (1998).  
Scale bar in lower right panel is 10 microns and applies to all panels. 
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Table 7:  Summary of mRNA granule colocalization in Long Evans rats with pMCAO.   
 Antigen Marker of 
CL with pA in 
contralateral  
cytoplasm 
CL with 
mRNA 
granules 
Figure 
No. 
PDI 
Endoplasmic 
reticulum partial No 16 
GM130 Cis-Golgi No No 17 
TGN38 Trans-Golgi No No 18 
Cytochrome C 
oxidase subunit 
IV 
Mitochondria No No 19 
α-tubulin Microtubules No No 20 
 
Neurofilament 
H/M 
Intermediate 
filaments No No 21 
 NeuN Nucleus No Yes 22 
Ribo P antigen 60S subunit Yes No 23 
HuR mRNA BP No Yes 24 
APRIL HuR cofactor No No 25 
pp32  HuR cofactor Minor, punctate No 26 
TIA-1 Stress granules Minor, punctate No 27 
 
TTP Processing 
bodies 
No No 27 
CL, colocalization. Other abbreviations as defined in the text. 
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CHAPTER FOUR: Effect of Diabetes - Methods and Results 
I. Rationale 
The systematic characterization of mRNA granule formation as a function of pMCAO 
duration in the Long Evans rat strain described in the previous chapter laid the framework to 
study the effect of diabetes on mRNA granule formation during focal cerebral ischemia.  
Combining the well-known fact that diabetes worsens outcome after focal ischemia with the new 
insight obtained from the time course and 3D distribution of neurons containing mRNA granules 
as a function of pMCAO duration described in Chapter 3 (Figure 15), it seemed reasonable to 
anticipate that diabetes might serve to accelerate the time course such that cessation of mRNA 
granule formation occurred at an earlier duration of pMCAO than the 8 hr pMCAO in the non-
diabetics.  I therefore repeated the design of the experimental groups in Chapter 3, but shortened 
the time course of pMCAO to cover the range 30 min to 6 hrs.  Quite unexpectedly, this change 
did not make a difference to the results.  As we describe in this chapter, diabetes completely 
inhibited mRNA granule formation in neurons during pMCAO. 
II. Materials 
STZ was purchased from Sigma Chemical Co. (St. Louis, MO). All other materials used 
were previously described in Chapters 2 and 3. 
III. Methods   
A. Animal model 
An insulinopenic model of diabetes was induced in 8-week old male Long Evans rats by 
a single intraperitoneal (IP) injection of STZ (50 mg/kg dissolved in 0.1 mM sodium citrate, pH 
4.5)104,115.  Left hind limb saphenous vein blood samples were collected one week after STZ 
injection and plasma glucose was determined using an Accu-Chek® Advantage glucometer 
(Roche Diagnostics, Indianapolis, IN).  Diabetes was defined by a blood glucose > 300 mg/dl, 
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with animals being used 4-6 weeks later without insulin supplements.  Average blood glucose for 
the STZ-treated rats at the time of MCAO was 437 mg/dL ± 49.5. Unilateral focal brain ischemia 
was induced using the same model of MCAO described in Chapter 2.  Diabetic experimental 
groups are listed in Table 8.  NIC-d is the sham operated diabetic rats not subject to MCAO. 
Table 8: Diabetic Long Evans experimental groups. 
Experimental Group Ischemia Reperfusion n 
NIC-d  - - 3 
0.5I-d 30 min - 4 
1I-d 1hr - 4 
2I-d 2 hr - 4 
4I-d 4hr - 4 
6I-d 6hr - 4 
B. TTC staining 
TTC staining was performed as described in Chapter 2.  Only the 6I-d group was stained.  
C. Immunofluorescence (IF) and Fluorescent in situ hybridization 
Double-labeling PABP IF and pA FISH were performed as described in Chapter 2. 
D. Volumetric reconstruction of pA staining 
3D reconstruction of the brain following diabetes plus pMCAO 
was performed exactly as described in Chapter 3. 
IV. Results 
A. TTC staining 
TTC staining was used to evaluate infarct volume in 
insulinopenic, chronically diabetic male Long Evans rats.  Representative 
samples are shown in Figure 29. The NIC-d showed normal, deep red 
TTC staining, as did the 6I-d group.  Since no infarct was observed in the 
6I-d group, earlier time points of pMCAO were not tested for TTC 
staining. Figure 29:  TTC staining in diabetic Long Evans rats following 6 hr pMCAO. 
Figure 29 : TTC staining in 
diabetic Long Evans rats 
following 6 hr pMCAO 
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B. Animal condition and mRNA granule frequency  
Diabetic animals had average blood glucose of 437 ± 49.5 mg/dl and average weight loss 
of 4.57 ± 0.53 grams.  This weight loss was not different from the variance of non-diabetic Long 
Evans used in Chapter 3. Three of the animals displayed muscle wasting and two of them 
developed cataracts. 
Following histological examination of pA FISH/PABP IF stained slides no mRNA 
granules were detected in any neurons in any diabetic pMCAO group.  The diabetic animals 
showed only shrunken and distorted, core-like areas of pA/PABP staining (data not shown, but 
essentially identical to Figure 14, top panel, core sample).  Therefore, extensive colocalization 
studies such as described in Chapters 2 and 3 could not be performed. 
C. Volumetric analysis 
Volumetric analysis was performed as previously described in Chapter 3.  Using the 
sequential cross sections, 3D volumes for the distorted/shrunken core neuronal phenotype of the 
experimental groups was generated (Figure 30).   As indicated above, no mRNA granules were 
observed in neurons at any pMCAO duration, and therefore, reconstructed volumes show only 
the volumes of shrunken distorted neurons in red.  Unlike the non-diabetics, some of the diabetic 
samples showed shrunken distorted neurons in the contralateral hemisphere and representative 
samples are shown for the 4I-d and 6I-d samples in Figure 30.  One of the 1I-d samples and two 
each of the 4I-d and 6I-d samples showed bilateral damage.  The volume of shrunken/distorted 
neurons in the contralateral hemisphere did not exceed 10% of the total affected volume. 
 Since no mRNA granules formed in neurons of diabetic MCAO animals, relative 
volumes could not be calculated.  Instead, the “absolute” percent of affected brain was taken as 
the volume of core divided by the volume of one hemisphere of the LONI dataset and is plotted 
in Figure 30 (brown curve).  In the 0.5I-d group, 27.7 ± 6.5% of the hemisphere volume had 
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shrunken/distorted neurons and this increased to 40.1 ± 9.0%, 46.9 ± 14% and 49.2 ± 17% at 1I, 
4I and 6I, respectively.  There was no statistical difference amongst the diabetic 1I, 4I and 6I 
groups, however, the 0.5I-d group differed statistically from the aforementioned groups 
(ANOVA p = 0.044, Tukey post hoc p = 0.032). 
Also shown on the plot of Figure 30 is the percent of the LONI hemisphere volume taken 
up by the sum of the non-diabetic mRNA granule and non-diabetic core volumes (which had 
been shown as relative percents in Figure 15).  When summed in this fashion the 1I, 2I, 4I and 8I 
percents of the LONI volume were 50.0 + 26.9 %, 60.6 + 15.8 %, 68.7 + 11.3 %, and 63.7 + 0.0 
%, respectively.  None of these summed volumes cleared statistically.  Further, when an 
ANOVA was run comparing the 2I and 4I pMCAO time points between the diabetic and non-
diabetic samples, these did not clear statistically (ANOVA p = 0.327). 
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Figure 30:  3D reconstructions following pMCAO in diabetic rats. 
Left: Representative 3D reconstructions of volumes of tissue containing shrunken/distorted 
neurons as identified by PABP/pA IF/FISH.  Right: Percent of one hemisphere of the LONI 
dataset occupied by the core volume in diabetics (brown curve) or the core plus mRNA granule-
containing volumes of the non-diabetics (cyan curve).  The red and green curves are the averages 
of the volumes of the core and mRNA granule volumes, respectively, that are summed together 
to form the cyan curve.  Red and green curves are shown for reference, and are shown without 
error bars to minimize distractions on the chart.  Error bars on the cyan curve are the combined 
errors of the sum of the red and green curves. * Post hoc p < 0.05 for 0.5I-d compared to other 
diabetic groups. 
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There are two interesting conclusions drawn from the plot in Figure 30.  First, diabetes 
did not increase the total volume of tissue affected by the pMCAO.  The total volumes in both 
the diabetic and non-diabetic samples converged to roughly 50% of the reference volume, which 
was taken as one hemisphere of the rendered LONI dataset.  Instead, and contrary to my 
hypothesis, diabetes did not increase the extent of injury after MCAO; it completely inhibited 
formation of the mRNA granules at any time point of MCAO. 
Second, when the non-diabetic data is expressed as a percent of the reference volume, the 
sum of the mRNA granule-containing volume and the core volumes was essentially constant.  As 
can be seen from the red and green lines on the plot of Figure 30, there was an exponential 
conversion of the mRNA granule containing volume to core volume as the duration of pMCAO 
increased. 
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CHAPTER FIVE:  Discussion 
I. Summary of Results 
In the previous chapters I have described my studies assessing the histology of pA 
mRNAs in the rodent brain following focal ischemia.  My main findings were: 
1. In Wistar rats no infarct was detected out to 7 days reperfusion after 2 hr MCAO.  
Granulation of mRNA was sporadic and occurred at low frequency only in the 2I samples 
and was unaffected by anesthetic. The mRNA granules detected had the colocalization 
properties seen after global brain ischemia102. 
2. The frequency of mRNA granule-containing neurons was much greater in the Long Evans 
rat strain in the 2I group compared to the Wistar strain.  Following 2 hr MCAO and 24 hr 
reperfusion, Long Evans rat brains showed a necrotic core. 
3. The mRNA granules in the Long Evans rats following pMCAO… 
a. Were detected in layers II/III, V and VI of cerebral cortex, and striatum, and 
they occurred in ipsilateral penumbra. 
b. Had the colocalization properties seen after global brain ischemia102. 
c. Did not colocalize with markers of ribosomal subunits or organelles but did 
colocalize with NeuN. 
d. Decreased in frequency with increased during of pMCAO and were not 
detected in the 8I group. 
4. The volume occupied by mRNA granule-containing neurons transformed into a core-like 
shrunken and distorted neuronal phenotype with increased duration of pMCAO. 
5. Diabetes inhibited formation of mRNA granules in neurons at all durations of pMCAO 
tested. 
6. The volume of tissue showing distorted/shrunken neurons in diabetic samples approached 
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the same volume of core tissue in non-diabetics with increased duration of pMCAO. 
In this chapter I will discuss the significance of these findings with respect to other 
studies in the literature and also with respect to new insights they provide about the response of 
the brain to focal ischemia and the response of the diabetic brain to focal ischemia. 
II. Differences between Rat Strains 
To begin, there was a striking difference in the way the Wistar and Long Evans rats 
responded to MCAO ischemia. Previous studies from other labs indicate a number of factors that 
would predispose the Wistar strain to be more resistant to a given ischemic stimulus compared to 
the Long Evans strain. 
A. Strain Differences in Outcome 
Wistar rats, compared to other common laboratory rat strains, were shown to have a 
greater number of MCA-ACA anastomoses or collaterals106.  Collateral flow becomes important 
during focal ischemia to compensate in regions downstream of a focal occlusion124 to increase 
blood flow to core and penumbra116.  The importance of collateral flow was demonstrated by 
Oliff et al. who showed that when collateral flow was reduced by bilateral CCA occlusion, there 
was a significant increase in the mean cortical infarct volume116,124.  In addition, subcortical 
regions like the striatum receive blood supply almost exclusively from the lateral striate arteries 
that originate from the MCA.  Since these arteries are end-arterioles, the caudate-putamen does 
not receive sufficient collateral blood flow to keep the tissue viable following MCAO106.  Most 
of the strain difference findings suggest that variations in outcome of focal ischemia may not be 
a technical issue, but may have to do with the type of animals used116.  Thus, increased collateral 
blood flow is one explanation of why Wistar rats were more resistant to focal ischemia compared 
to Long Evans rats106,116. 
In addition to vascular anatomical differences, using laser Doppler flowmetry, Long 
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Evans rats demonstrated a more persistent and pronounced stable drop in cortical local cerebral 
blood flow (LCBF)  (74.6 ± 8.9%)  following 60 minutes of transient MCAO when compared to 
Wistar rats (49.0 ± 21.9%)117.  The differences in blood flow could not be fully accounted for by 
anatomical differences in the vasculature and these authors speculated that intrinsic blood flow 
regulatory mechanisms may be more robust in the Wistar strain. 
Factors such as these, allowing Wistars to maintain a higher blood flow during the 
MCAO period, could explain why, after 2 hr MCAO, the Wistar rat failed to show an infarct 
even out to 7 days reperfusion and the Long Evans strain showed an infarct at 24 hr reperfusion. 
B. Strain Differences in mRNA granule Formation 
The studies described above can also be used to explain why the incidence of mRNA 
granule formation was so much less in the Wistar compared to the Long Evans rats. Work from 
Hossmann’s lab has measured many different metabolic and functional thresholds that occur at 
specific decrements of cerebral blood flow (CBF)124.  For example, CBF must decrease below 
20% for ATP levels to drop precipitously and for neurons to dissipate ion gradients118.   
Hossmann has documented that the threshold for TA occurs at ~ 50% reduction in CBF119.  
Based on the CBF study conducted by Prieto et al117, CBF during MCAO averages around 50% 
in the Wistar, but averages around 30% for the Long Evans.  Thus, the Wistar, on average, 
hovers at the threshold of TA onset, but the Long Evans is substantially below the 50% CBF 
threshold.  Formation of mRNA granules has been shown to be a morphological correlate of 
TA102, specifically because mRNA is sequestered away from ribosomal subunits.  Therefore, the 
same explanation for improved outcome in the Wistar strain also provides a plausible 
explanation for the relative lack of mRNA granule formation following MCAO in this strain.  
Although protein synthesis was not directly measured in the studies described here, my results 
lead to the prediction that there would not be a cessation of protein synthesis in the Wistar brain 
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at least out to 2 hr MCAO and for any subsequent reperfusion duration.  Indirect support for this 
prediction from the present studies was that I observed the successful translation of HSP70 
protein in the Wistar strain at various durations of reperfusion (Figure 9).  It is well documented 
that HSP70 translation does not occur in neurons destined to die by DND in both focal and 
global brain ischemia models, specifically because of the prolonged TA1,86. 
III. mRNA Granules in Focal Ischemic Neurons 
 Our previous study showed mRNA granules form following global brain ischemia102.  
The present study is the first demonstration of mRNA granule formation following focal brain 
ischemia.  I performed extensive colocalization studies (Figure 12 and Figure 13) in order to 
determine if the mRNA granules that formed following focal ischemia were the same as those in 
the global model.  Furthermore, I have extended the colocalization studies beyond those we 
published in the global model to assess cell organelles and additional mRNA binding proteins 
(Figures 16-28). 
As stated above, the mRNA granules seen after MCAO failed to colocalize with the 40S 
and 60S ribosomal subunits.  Presently, this is their most important characteristic as it provides 
an explanation for what has been an outstanding unresolved problem in the field, which is the 
cause of prolonged TA in post-ischemic brain neurons.  
However, the additional colocalization studies begin to address more specifically what 
the mRNA granules are, and are not.  They did not colocalize with markers of the ER or for cis- 
and trans-Golgi network.  Thus, even though the mRNA granules are intimately involved with 
the translational system, they are not involved in the main proximal secretory systems for 
secreted and membrane localized protein synthesis.  I also tested two markers of the 
cytoskeleton: -tubulin and neurofilament proteins H/M.  The lack of colocalization indicates the 
mRNA granules are not formed in association with microtubules or intermediate filaments.  I had 
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tried several actin antibodies to look at the actin system, but was unable to get any of the tested 
actin antibodies to work in the FISH/IF double labeling procedure.  Thus, the association of 
mRNA granules with the microfilament system is unresolved by my studies.  The mRNA 
granules also did not colocalize with COX IV, a mitochondrial marker.  Therefore, my studies 
rule out these organelle systems as playing a direct role in mRNA granule function. 
Similar to the results with global brain ischemia102, the mRNA granules did not 
colocalize with TIA-1 or TTP and therefore are not stress granules or processing bodies. They 
did colocalize with the known mRNA binding proteins PABP and HuR.  Thus, the mRNA 
granules observed in the focal model are very similar to, if not identical to, those observed 
following global brain I/R. 
However, one surprising finding was the colocalization of the cytoplasmic mRNA 
granules with NeuN, a neuronal nuclei marker.  A recent study identified NeuN as the sequence-
specific mRNA splicing factor Fox-3.  Fox-3 is a component of nuclear speckles, which are 
morphological structures of the nuclear transcription and mRNA processing machinery that 
interacts with the nuclear matrix120.  That NeuN has been identified as a protein involved in 
nuclear mRNA processing is consistent with our observation that NeuN colocalized in the 
mRNA granules.  Furthermore, our result suggests that NeuN may function similarly to TIA-1, 
TTP and HuR, all of which are nuclear proteins involved in mRNA processing, but which 
translocate to the cytoplasm during cell stress and play roles in the ribonomic systems76-81. 
Since the mRNA granules colocalized with HuR, we tested two proteins known to 
function with HuR during the heat shock response: APRIL and pp32.  Both of these proteins 
bind to and complex with HuR and its client mRNAs to mediate nuclear to cytoplasmic 
translocation of mRNAs upregulated during heat shock79,80.  The logic of testing APRIL and 
pp32 was that if they colocalized with HuR and the mRNA granules, it would suggest all three 
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proteins were playing a role in the nuclear export of mRNAs.  However, neither APRIL or pp32 
colocalized in the mRNA granules, and this suggests HuR may be mediating a function different 
from that identified by the Steitz lab79.  
To summarize the colocalization studies, the mRNA granules detected after MCAO share 
the same characteristics as those seen after global ischemia, indicating they are likely the same 
structures.  Further, the mRNA granules are not substantially colocalized with organelles but 
only select mRNA binding proteins. 
IV. Time Course of mRNA granules in pMCAO 
The observation that the relative proportions of mRNA granule-containing neurons 
decreased with pMCAO (plot, Figure 15), but that the sum of the volumes of mRNA granule-
containing plus core-like neurons remained constant with pMCAO duration (plot, Figure 30) is 
one of the significant findings of my work.  This observation is relevant to how penumbral 
neurons convert to core neurons and my findings contribute new insights to how this occurs.   
As stated in the Background, rescuing the penumbra in an effort to improve outcome 
following an ischemic event is the goal of stroke research.  There are two general approaches to 
stroke therapy.  Therapies that induce reperfusion have had some success via surgical techniques 
and with application of tissue plasminogen activator (tPA).  But even tPA usage occurs at the 
risk of hemo-compromising patients121. Neuroprotective strategies to halt the cause of cell death 
of penumbral neurons have been spectacular failures: every single one of over 100 clinical trials 
of stroke neuroprotection have failed122,123.  Thus, the new insights into how potentially 
salvageable penumbral neurons convert to core-like neurons irreversibly committed to die are 
significant for the possibility of offering new neuroprotective strategies in the long run.   
There are different mechanisms of penumbra-core conversion whether focal ischemia is 
transient or permanent, and whether the ischemia is occlusive or hemorrhagic124.  Since I only 
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investigated permanent occlusive focal ischemia, my work applies only to this case.  
The two images shown in Figure 31 are taken from a 2009 review by Hossmann on the 
pathophysiology of stroke injury and show the changes in the brain following pMCAO.  The plot 
in Figure 31A shows how blood flow changes throughout the core area as a function of pMCAO 
duration.  CBF is initially at its lowest, but increases somewhat as collateral circulation 
compensates for the occlusion. It should be noted he shows CBF to decrease to zero, but above I 
discussed that the average CBF decreases during rodent MCAO range from ~ 20-50% normal 
CBF. 
The plot in Figure 31B shows the evolution of the infarct core with pMCAO duration.  It 
can be seen how this rapidly increases and is almost maximum at 3 hr pMCAO and is maximum 
by 6 hr pMCAO.  I have added to Figure 31B the curve of my results of the decrease in the 
volume of tissue where the neurons contained mRNA granules (green curve).  It is striking that 
the decrease in mRNA granules is roughly a mirror image of the evolution of the infarct core.  
This decrease occurs in spite of the minor increase in CBF shown in the plot in A.  Thus, the loss 
of ability of neurons to form mRNA granules directly correlates with production of infarct core. 
It is also significant that I observed a rapid loss of mRNA-granule containing neurons 
between 2 and 4 hr pMCAO.  This is precisely the time window that Hossmann has indicated as 
“therapeutic window” on his plot in Figure 31B.  This correspondence would suggest that if we 
understood exactly why the neurons lost the ability to form mRNA granules with increased 
pMCAO duration, that this might be an important therapeutic target, and perhaps extend the 
duration of the “therapeutic window” shown in Dr. Hossmann’s graph. 
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Figure 31: Changes in blood flow and core evolution during pMCAO.  Adapted from 124. 
 
V. Inhibition of mRNA Granulation by Diabetes 
It was an unexpected finding that diabetes led to a complete inhibition of mRNA granule 
formation.  It is well known that chronic diabetes causes a plethora of complications all of which 
have a negative impact on stroke outcome.   These can be classified into three general categories: 
immunological, vascular and cellular.  Each could plausibly contribute to the inhibition of the 
mRNA granules. 
There is a series of processes in the inflammatory response that are associated with post-
ischemic reperfusion that exacerbate brain injury even when diabetes is not present115.    Chronic 
diabetes induces exaggerated inflammatory responses to brain I/R due to increase in leukocyte 
adhesion and emigration mediated by CD11/CD18-ICAM-1 and P-selectin and albumin 
leakages125.  Matrix metalloproteinases (MMP), which are involved in the physiological turnover 
of the extracellular matrix, contribute to blood brain barrier leakage and cellular damage 
following focal brain I/R.  MMP-2 and MMP-9 have been implicated in cerebral ischemia. 
MMP-9 is normally absent in brain but upregulated in response to injury.  Early inhibition of 
MMP-9 led to reduction in infarct size at two weeks following permanent MCAO125.  Such 
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adverse inflammatory responses would converge to create an extracellular environment that 
would upset the highly specific conditions required for neuronal function.  In this way, 
inflammatory factors would serve to generally decrease neuronal fidelity, and this may 
contribute to diabetes inhibition of mRNA granule formation. 
There is an increased risk of endothelial cell dysfunction and vascular smooth muscle 
impairment associated with chronic diabetes.19  Diabetics were also shown to have impaired 
endothelium-dependent, nitric oxide-mediated vasodilation126.  Hyperglycemia inhibits the 
production of nitric oxide via eNOS activation, thus blocking a potent vasodilator.  Furthermore, 
when diabetes is present, there is also an increase in the production of vasoconstrictors, such as 
endothelin-1127.  Studies have also shown impairment in collateral recruitment in chronic 
diabetes.128.  Such vascular abnormalities in chronic diabetes may also contribute to the 
inhibition of mRNA granules in penumbral neurons, following diabetic MCAO.  The vascular 
abnormalities would collectively serve to increase the intensity of the ischemic insult following 
MCAO, rendering the neurons incapable to respond properly to stress and leading to a greater 
volume of core-like neurons. 
Finally, diabetes alters intracellular conditions in generally adverse ways.  Examples 
include: decreased pH of the cytoplasm129, increased production of free radical species130,131, 
inhibition of the oxidative phosphorylation of mitochondria132, and the activation of the intrinsic 
apoptotic pathways96,104.  All of these are direct forms of damage inside the neuron, and as such, 
they could converge to inhibit the molecular mechanism of mRNA granule formation.  For 
example, one could hypothesize that some crucial or rate limiting component needed for the 
formation of the mRNA granules is damaged by oxidative stress, or altered intracellular pH, 
rendering them inactive.  Another possible mechanism is that some crucial component of the 
mRNA granules is a substrate of caspase 3 and degraded.   
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Thus, there are a number of plausible, experimentally testable hypotheses as to why 
diabetes inhibits mRNA granule formation. 
VI. Limitations of the Present Studies 
There are several limitations of the present study. 
1. On one hand, the present study could be considered to be purely descriptive.  There were 
no drug interventions or genetic knockouts used in the present work in the attempt to 
establish mechanism by the currently acceptable route.  On the other hand, a histological 
demonstration that mRNA does not colocalize with ribosomal subunits is itself a 
mechanism of TA, one that has eluded 40 years of biochemical and molecular biological 
studies on ischemic brains.  Whether one frames the present work as descriptive or 
mechanistic, it has clearly identified new phenomena that open up new and clinically 
important lines of research into two of the biggest clinical problems today: stroke and 
diabetes. 
2. No attempt was made to ascertain information about molecular mechanisms of the 
formation or the function of the mRNA granules.  However, that diabetes inhibits their 
formation provides a system that can be used in the future to begin to address the 
mechanisms of their formation. 
3. As described in the previous section, diabetes leads to a large number of possible 
mechanisms for the inhibition of mRNA granule formation.  The present studies did not 
investigate any of these. 
VII. Future Directions 
Future directions follow directly from the limitations of the present study: 
1. Seek information about the molecular mechanisms of mRNA granule formation, and 
about their role and function in the neurons of the ischemic and reperfused brain.  Some 
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ways to begin to move in this direction would be to use specific pharmacologic agents or 
to use genetic knockouts to assess the role of specific proteins in either mRNA granule 
formation of function.  For example, as described in Background, Ca2+ ion is a critical 
trigger for many subsequent molecular changes in the neurons after ischemia.  Calcium 
channel blockers or NMDA antagonists could be used to determine if Ca2+ also plays an 
upstream role in mRNA granule formation.  Another example would be to administer 
agents that directly alter the translational system.  For example, cycloheximide is a well 
known protein synthesis inhibitor whose mode of operation is to prevent polysomes from 
dissociating. Since it is well known that polysomes dissociate in neurons after I/R, would 
preventing their dissociation with cycloheximide alter mRNA granule formation?  
Genetically altered mice could also be used in a similar fashion to test the role of specific 
proteins. 
2. The present work studied specifically mRNA granules after pMCAO.  Now that the time 
course of mRNA granule formation in pMCAO has been identified, the next step is to 
study a time course of transient MCAO, and assess the mRNA granules and how they 
correlate with outcome.  For example, I can now predict that following 2hr MCAO, there 
should be mRNA granules for at least some duration of subsequent reperfusion.  
However, following 8 hr MCAO, there should be no mRNA granules at subsequent 
reperfusion durations. 
3. Another future direction is to begin to study specific adverse effects of diabetes to see 
which may be involved in the inhibition of mRNA granule formation.   Some of these 
effects can be separated from diabetes, such as hyperglycemia.   
VIII. Summary and Conclusions 
I had hypothesized that mRNA granules form in brain after focal ischemia.  My research 
92 
 
showed how this phenomenon is dependent on the strain used, which, based on information from 
the literature, was related to blood flow rates during MCAO, and hence the amount or degree of 
ischemia generated in the different rat strains.  I have contributed new insights into how 
penumbral brain tissue converts to core as ischemia duration increases.  Neurons that might have 
survived at lesser durations of focal ischemia no longer form mRNA granules with increased 
ischemia duration.  Previously this had been understood only in terms of “threshold” 
magnitudes118, but my work begins to identify specific cellular mechanisms mediating this 
conversion in neuronal phenotypes.  Finally, the work reported here discovered the unexpected 
finding that diabetes completely abrogates the mRNA granule response in the neurons of the 
focal ischemic brain.  This adds an additional effect of diabetes on brain that clearly will 
contribute to worsened outcome in the diabetic brain after stroke and opens up a new line of 
investigation into how diabetes exerts adverse affect on ribonomic pathways in neurons. 
As the work I did relied on the work of other researchers before me, I sincerely hope my 
work can be a stepping stone for future studies that will lead to a clear and full understanding of 
the insidious effects of both diabetes and stroke and lead one day to successful treatments that 
can alleviate the pain and suffering of both stroke victims and diabetic patients. 
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ABSTRACT 
 
MECHANISMS OF TRANSLATION ARREST FOLLOWING FOCAL BRAIN 
ISCHEMIA 
by 
MONIQUE K. LEWIS 
   August 2011 
Advisor: Donald J. DeGracia, Ph.D. 
Major:   Physiology 
Degree:  Doctor of Philosophy 
Diabetes affects 25 million and stroke affects ¾ million people a year in the USA. 
Diabetes increases the risk of stroke and worsens stroke outcome, but the causes for this are not 
fully known.  Neurons destined to die following brain ischemia undergo a persistent translation 
arrest that prevents successful expression of protective cellular responses.  Recent work has 
revealed the translation arrest following global ischemia is due to sequestration of mRNA in the 
form of mRNA granules away from ribosomal subunits, thereby precluding translation.  I 
hypothesize that mRNA granules form during focal brain ischemia and this effect is worsened in 
diabetics subjected to focal brain ischemia.  MCAO was performed for durations ranging from 2-
8 hr and mRNA granules assessed by fluorescence in situ histochemistry. Long Evans rats 
showed strong mRNA granule formation in penumbra at 2 hr ischemia but not Wistar rats.  In the 
Long Evans strain, the volume of brain containing neurons expressing mRNA granules 
decreased exponentially from 2 to 8 hr focal brain ischemia such that no mRNA granules were 
detected at 8 hr ischemia.  Colocalization studies of mRNA granules with a panel of organelle 
and mRNA binding protein markers showed these to colocalize with PABP, HuR and NeuN.  
mRNA granules did not colocalize with markers of ribosomal subunits, endoplasmic reticulum, 
cis- and trans-Golgi networks, mitochondria, microtubules, intermediate filaments, stress 
granules, processing bodies or the HuR accessory proteins APRIL and pp32.  Diabetes 
completely abrogated the formation of mRNA granules following any duration of focal ischemia 
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tested.  Thus, mRNA granules form in penumbral neurons following focal brain ischemia and 
mediate translation arrest in these neurons.  This response is inhibited by diabetes.  Since mRNA 
granules are part of the ribonomic regulation of neuronal stress responses, their inhibition by 
diabetes provides an additional mechanism whereby diabetes worsens outcome after focal brain 
ischemia. 
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